Kypros Nicolaides
#15,197
Most Influential Person Now
Greek-Cypriot fetal medicine specialist
Kypros Nicolaides's AcademicInfluence.com Rankings
Kypros Nicolaidesphilosophy Degrees
Philosophy
#1450
World Rank
#2634
Historical Rank
Logic
#208
World Rank
#452
Historical Rank
Download Badge
Philosophy
Kypros Nicolaides's Degrees
- Masters Fetal Medicine King's College London
Why Is Kypros Nicolaides Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kyprianos "Kypros" Nicolaides is a Greek Cypriot physician of British citizenship, Professor of Fetal Medicine at King's College Hospital, London. He is one of the pioneers of fetal medicine and his discoveries have revolutionised the field. He was elected to the US National Academy of Medicine in 2020 for 'improving the care of pregnant women worldwide with pioneering rigorous and creative approaches, and making seminal contributions to prenatal diagnosis and every major obstetrical disorder'. This is considered to be one of the highest honours in the fields of health and medicine and recognises individuals who have demonstrated outstanding professional achievement and commitment to service.
Kypros Nicolaides's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia (2017) (1175)
- Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. (1992) (970)
- Progesterone and the risk of preterm birth among women with a short cervix. (2007) (950)
- A screening program for trisomy 21 at 10–14 weeks using fetal nuchal translucency, maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A (1999) (604)
- Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. (2004) (599)
- Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study (2011) (592)
- Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis (2015) (589)
- The hidden mortality of monochorionic twin pregnancies (1997) (580)
- Screening for fetal aneuploidies at 11 to 13 weeks (2011) (573)
- Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study (1999) (545)
- Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation (2001) (520)
- Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia (2003) (513)
- Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. (2012) (503)
- Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery (1998) (479)
- Multicenter study of first‐trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk‐orientated two‐stage first‐trimester screening (2005) (477)
- Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia (2007) (475)
- Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy (1996) (473)
- Fetal biometry at 14–40 weeks' gestation (1994) (471)
- Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers (2012) (469)
- Predictors of Neonatal Outcome in Early- Onset Placental Dysfunction (2007) (452)
- First-Trimester Prediction of Hypertensive Disorders in Pregnancy (2009) (444)
- Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks (2011) (442)
- Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation (2001) (432)
- The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis (2017) (431)
- Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation (1998) (427)
- Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis (2017) (424)
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. (2016) (423)
- Challenges in the diagnosis of fetal non‐chromosomal abnormalities at 11–13 weeks (2011) (423)
- The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention (2019) (414)
- Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection (2007) (405)
- Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies. (1995) (402)
- Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A (2008) (380)
- Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (2009) (375)
- Uterine artery Doppler at 11 + 0 to 13 + 6 weeks in the prediction of pre‐eclampsia (2007) (373)
- Blood gases, pH, and lactate in appropriate- and small-for-gestational-age fetuses. (1989) (372)
- First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications (2000) (371)
- Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis (2012) (360)
- Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. (1987) (359)
- One‐Stage Screening for Pregnancy Complications by Color Doppler Assessment of the Uterine Arteries at 23 Weeks' Gestation (2000) (356)
- ISUOG Practice Guidelines: role of ultrasound in twin pregnancy (2016) (356)
- The lambda sign at 10–14 weeks of gestation as a predictor of chorionicity in twin pregnancies (1996) (354)
- Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. (2006) (350)
- Maternal age‐ and gestation‐specific risk for trisomy 21 (1999) (344)
- Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester (2001) (343)
- Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. (1991) (341)
- Fetal fraction in maternal plasma cell‐free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics (2013) (338)
- Ultrasonographically detectable markers of fetal chromosomal abnormalities (1992) (335)
- Maternal age and adverse pregnancy outcome: a cohort study (2013) (335)
- Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis (2017) (331)
- Increased nuchal translucency with normal karyotype. (2005) (328)
- Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years prospective experience (2003) (325)
- ULTRASOUND SCREENING FOR SPINA BIFIDA: CRANIAL AND CEREBELLAR SIGNS (1986) (324)
- Cervical cerclage for prevention of preterm delivery in woman with short cervix:randomised controlled trial (2004) (320)
- Middle cerebral artery flow velocity waveforms in fetal hypoxaemia (1990) (314)
- Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach (2010) (313)
- Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. (2012) (308)
- Screening for chromosomal abnormalities at 10–14 weeks: the role of ductus venosus blood flow (1998) (306)
- Progression of Doppler abnormalities in intrauterine growth restriction (2008) (305)
- Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. (2012) (299)
- Reference ranges for fetal venous and atrioventricular blood flow parameters (1994) (297)
- Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. (1988) (296)
- Current outcome of antenally diagnosed cystic lung disease. (2004) (292)
- Competing risks model in screening for preeclampsia by maternal characteristics and medical history. (2015) (291)
- Endoscopic laser coagulation in the management of severe twin‐to‐twin transfusion syndrome (1998) (288)
- Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta‐analysis of individual patient data (2017) (287)
- Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing (2011) (287)
- Maternal age and gestational age-specific risk for chromosomal defects. (1995) (283)
- Prenatal prediction of survival in isolated left‐sided diaphragmatic hernia (2005) (282)
- An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. (2005) (282)
- A novel approach to first‐trimester screening for early pre‐eclampsia combining serum PP‐13 and Doppler ultrasound (2005) (279)
- Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy (1994) (276)
- Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11–13‐week scan (2009) (274)
- Prevention of perinatal death and adverse perinatal outcome using low‐dose aspirin: a meta‐analysis (2013) (273)
- First‐trimester screening for trisomy 21 by free beta‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A: impact of maternal and pregnancy characteristics (2008) (269)
- Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. (2008) (269)
- Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre‐eclampsia (2008) (267)
- Fetal venous, intracardiac, and arterial blood flow measurements in intrauterine growth retardation: relationship with fetal blood gases. (1995) (265)
- One‐stop clinic for assessment of risk for trisomy 21 at 11–14 weeks: a prospective study of 15 030 pregnancies (2002) (259)
- Doppler measurements of fetal and uteroplacental circulations: relationship with umbilical venous blood gases measured at cordocentesis. (1990) (257)
- Absence of nasal bone in fetuses with trisomy 21 at 11–14 weeks of gestation: an observational study (2001) (253)
- Second-trimester uterine artery Doppler screening in unselected populations: a review (2002) (249)
- Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. (2016) (248)
- Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results (2004) (246)
- Early prediction of severe twin-to-twin transfusion syndrome. (2000) (244)
- Fetal growth retardation: associated malformations and chromosomal abnormalities. (1993) (244)
- The role of uterine artery Doppler in predicting adverse pregnancy outcome. (2004) (241)
- ASPRE trial: performance of screening for preterm pre‐eclampsia (2017) (238)
- Prediction of pregnancy complications by first‐trimester maternal serum PAPP‐A and free β‐hCG and with second‐trimester uterine artery Doppler (2005) (238)
- Comparison of transvaginal digital examination with intrapartum sonography to determine fetal head position before instrumental delivery (2003) (237)
- Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y (2013) (236)
- Increased nuchal translucency at 10—14 weeks of gestation as a marker for major cardiac defects (1997) (236)
- Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. (1986) (235)
- Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks (2011) (233)
- Screening for triploidy by fetal nuchal translucency and maternal serum free β‐hCG and PAPP‐A at 10–14 weeks of gestation (2000) (232)
- Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A. (2008) (231)
- Therapeutic amniocentesis in twin-twin transfusion syndrome appearing in the second trimester of pregnancy. (1992) (231)
- Meta‐analysis of second‐trimester markers for trisomy 21 (2013) (230)
- A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment (2011) (227)
- Early Administration of Low-Dose Aspirin for the Prevention of Severe and Mild Preeclampsia: A Systematic Review and Meta-Analysis (2012) (226)
- Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations (2017) (226)
- A mixture model of nuchal translucency thickness in screening for chromosomal defects (2008) (225)
- Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10–14 weeks (1999) (224)
- Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency (1995) (223)
- Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing (2014) (223)
- Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 1l–13 weeks of gestation (1996) (219)
- Early Prediction of Preeclampsia (2014) (216)
- Screening for chromosomal defects (2003) (215)
- Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation (1996) (214)
- Measurement of fetal urine production in normal pregnancy by real-time ultrasonography. (1989) (209)
- Preinduction sonographic measurement of cervical length in the prediction of successful induction of labor (2001) (209)
- Low levels of maternal serum PAPP‐A in the first trimester and the risk of pre‐eclampsia (2008) (206)
- Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation (1994) (205)
- Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. (1989) (204)
- Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome (1995) (202)
- FETAL HAEMOGLOBIN MEASUREMENT IN THE ASSESSMENT OF RED CELL ISOIMMUNISATION (1988) (200)
- Nasal bone hypoplasia in trisomy 21 at 15–22 weeks' gestation (2003) (200)
- Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation (2012) (198)
- Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. (1990) (198)
- Prenatal diagnosis and outcome of echogenic fetal lung lesions (2008) (197)
- Prediction of patient‐specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population‐based prospective study (2006) (196)
- Combined Screening for Preeclampsia and Small for Gestational Age at 11–13 Weeks (2012) (195)
- A Competing Risks Model in Early Screening for Preeclampsia (2012) (194)
- Cervical cerclage for prevention of preterm delivery in women with a short cervix: A randomized, controlled trial (2005) (193)
- Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment (2008) (193)
- Comparison of diagnostic accuracy of early screening for pre‐eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE (2018) (192)
- Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11–14‐week scan (2004) (192)
- Intrapartum sonography to determine fetal head position (2002) (191)
- First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia (2009) (191)
- RAPID KARYOTYPING IN NON-LETHAL FETAL MALFORMATIONS (1986) (190)
- Assessment of lung area in normal fetuses at 12–32 weeks (2005) (188)
- Cervical length and funneling at 23 weeks of gestation in the prediction of spontaneous early preterm delivery (2001) (187)
- Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo‐controlled trial on the effect of vaginal micronized progesterone (2011) (186)
- Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation (2009) (186)
- Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 Weeks (2010) (185)
- Increased fetal nuchal translucency at 11–14 weeks (2002) (184)
- Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta‐analysis including data from the OPPTIMUM study (2016) (183)
- The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues (2002) (182)
- First‐trimester ultrasound screening for chromosomal defects (1996) (182)
- Fetal cardiac abnormalities identified prior to 14 weeks' gestation (2002) (181)
- Improvement in outcomes of multifetal pregnancy reduction with increased experience. (2001) (180)
- Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation (2017) (180)
- The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions. (1984) (180)
- Discordance in nuchal translucency thickness in the prediction of severe twin‐to‐twin transfusion syndrome (2007) (179)
- Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses. (1988) (177)
- Increased nuchal translucency thickness at l0–14 weeks of gestation as a predictor of severe twin‐to‐twin transfusion syndrome (1997) (176)
- Cervical length at 23 weeks of gestation: relation to demographic characteristics and previous obstetric history (1998) (176)
- Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation (2018) (174)
- Prenatal prediction of neonatal morbidity in survivors with congenital diaphragmatic hernia: a multicenter study (2009) (174)
- Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: Theoretical and empirical considerations. (2006) (174)
- Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: evolution of a technique and preliminary results. (2004) (173)
- Transvaginal Color Doppler Assessment of the Uteroplacental Circulation in Early Pregnancy (1991) (172)
- Megacystis at 10–14 weeks of gestation: chromosomal defects and outcome according to bladder length (2003) (172)
- Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks (2010) (171)
- Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation (2009) (170)
- Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies (2013) (167)
- Prediction of pre‐eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small‐for‐gestational age (2008) (164)
- Posterior brain in fetuses with open spina bifida at 11 to 13 weeks (2011) (163)
- Preliminary experience with endoscopic laser surgery for severe twin-twin transfusion syndrome. (1995) (163)
- The value of ultrasound in the prediction of successful induction of labor (2004) (163)
- First‐trimester biochemical markers of aneuploidy and the prediction of small‐for‐gestational age fetuses (2008) (162)
- Fetal Medicine Foundation fetal and neonatal population weight charts (2018) (162)
- Abnormalities of the heart and great arteries in first trimester chromosomally abnormal fetuses. (1997) (161)
- Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation (2009) (161)
- First-Trimester Prediction of Gestational Diabetes Mellitus: Examining the Potential of Combining Maternal Characteristics and Laboratory Measures (2010) (159)
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies. (2005) (159)
- Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one‐stop clinic: a review of three years experience (2003) (158)
- Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta‐analysis (2015) (158)
- Endoscopic laser coagulation of umbilical cord vessels in twin reversed arterial perfusion sequence (1994) (157)
- Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. (2013) (157)
- Cystic Adenomatoid malformation of the lung: Prenatal diagnosis and outcome (1994) (156)
- Analysis of Cell-Free DNA in Maternal Blood in Screening for Aneuploidies: Meta-Analysis (2014) (156)
- Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre‐eclampsia (2008) (156)
- Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free β‐hCG and PAPP‐A at 11 to 14 weeks (2003) (155)
- Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta‐analysis of individual patient data (2017) (154)
- Letter. Correct estimation of parameters for ultrasound nuchal translucency screening (1998) (153)
- Have Liley charts outlived their usefulness? (1986) (153)
- Value of prenatal magnetic resonance imaging in the prediction of postnatal outcome in fetuses with diaphragmatic hernia (2008) (152)
- Perinatal features associated with placental mesenchymal dysplasia. (1997) (152)
- Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6‐week scan (2005) (151)
- Fetal intervention for congenital diaphragmatic hernia: the European experience. (2005) (148)
- First‐trimester determination of fetal gender by ultrasound (1999) (148)
- Turning the Pyramid of Prenatal Care (2011) (147)
- Maternal age‐specific risks for trisomies at 9—14 weeks' gestation (1994) (147)
- Plasma insulin in appropriate- and small-for-gestational-age fetuses. (1989) (146)
- Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP‐A at 11–13 weeks (2010) (146)
- Ultrasound screening for anencephaly at 10–14 weeks of gestation (1997) (145)
- Quantification of cervical elastography: a reproducibility study (2012) (144)
- Fetal thyroid function. (1993) (143)
- The making of fetal surgery (2010) (143)
- Fetal lung-to-head ratio in the prediction of survival in severe left-sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO). (2006) (143)
- Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype (2001) (143)
- MATERNAL OXYGEN THERAPY FOR INTRAUTERINE GROWTH RETARDATION (1987) (142)
- Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks (2009) (142)
- Maternal and neonatal outcomes in women undergoing bariatric surgery: a systematic review and meta-analysis. (2014) (140)
- Absent nasal bone at 11–14 weeks of gestation and chromosomal defects (2003) (140)
- Fetal megacystis at 10–14 weeks of gestation (1996) (139)
- Ethnicity and the need for correction of biochemical and ultrasound markers of chromosomal anomalies in the first trimester: a study of Oriental, Asian and Afro‐Caribbean populations (2005) (137)
- Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial. (2014) (137)
- Renal artery flow-velocity waveforms in normal and hypoxemic fetuses. (1989) (137)
- The 11-14 week scan: the diagnosis of fetal abnormalities (1999) (137)
- First‐trimester maternal factors and biomarker screening for preeclampsia (2014) (136)
- Relation Between Increased Fetal Nuchal Translucency Thickness and Chromosomal Defects (2006) (136)
- First‐Trimester Fetal Nuchal Translucency Thickness and Risk for Trisomies (1994) (135)
- Fetal Fraction in Maternal Plasma Cell-Free DNA at 11–13 Weeks’ Gestation: Effect of Maternal and Fetal Factors (2012) (135)
- Trisomy 13 detection in the first trimester of pregnancy using a chromosome‐selective cell‐free DNA analysis method (2013) (133)
- Diagnosis of fetal non‐chromosomal abnormalities on routine ultrasound examination at 11–13 weeks' gestation (2019) (133)
- First-Trimester Circulating 25-Hydroxyvitamin D Levels and Development of Gestational Diabetes Mellitus (2011) (132)
- Rh disease: intravascular fetal blood transfusion by cordocentesis. (1986) (131)
- One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester (2000) (130)
- Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix (1998) (129)
- Metabolic and endocrine findings in appropriate and small for gestational age fetuses (1991) (129)
- Prediction of morbidity in small and normally grown fetuses by fetal heart rate variability, biophysical profile score and umbilical artery Doppler studies (1993) (128)
- Nasal bone assessment in prenatal screening for trisomy 21. (2006) (128)
- Mean Arterial Pressure at 11+0 to 13+6 Weeks in the Prediction of Preeclampsia (2008) (127)
- Prospective validation of first‐trimester combined screening for trisomy 21 (2009) (126)
- Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (126)
- Results of fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia and the set up of the randomized controlled TOTAL trial. (2011) (126)
- Assessment of risk for the development of pre‐eclampsia by maternal characteristics and uterine artery Doppler (2005) (126)
- First-trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. (2001) (125)
- Measurement of human fetoplacental blood volume in erythroblastosis fetalis. (1987) (125)
- Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21. (2005) (125)
- Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks (2009) (125)
- Investigation of occiput posterior delivery by intrapartum sonography (2004) (125)
- A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth. (2016) (124)
- Prediction of pre‐eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy‐associated plasma protein‐A, free β‐human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks' gestation (2006) (124)
- Lung and heart volumes by three‐dimensional ultrasound in normal fetuses at 12–32 weeks' gestation (2006) (124)
- From nuchal translucency to intracranial translucency: towards the early detection of spina bifida (2010) (124)
- Nasal bone in first-trimester screening for trisomy 21. (2006) (124)
- Lung volumes in fetuses with congenital diaphragmatic hernia: comparison of 3D US and MR imaging assessments. (2007) (123)
- First‐trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell‐free DNA testing (2013) (123)
- The role and interaction of imprinted genes in human fetal growth (2015) (123)
- Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins. (2006) (123)
- Prediction of pre‐eclampsia by a combination of maternal history, uterine artery Doppler and mean arterial pressure (2008) (122)
- Aspirin for Evidence‐Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history (2017) (122)
- Fetal Blood Velocities in Rh Isoimmunization: Relationship to Gestational Age and to Fetal Hematocrit (1986) (121)
- Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency (1999) (120)
- Repeatability of measurement of fetal nuchal translucency thickness (1995) (120)
- Birthweight with Gestation and Maternal Characteristics in Live Births and Stillbirths (2012) (120)
- Cervical assessment at the routine 23‐week scan: standardizing techniques (2001) (120)
- Maternal weight correction of maternal serum PAPP‐A and free β‐hCG MoM when screening for trisomy 21 in the first trimester of pregnancy (2003) (119)
- First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing (2013) (119)
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery (2008) (119)
- Fetal gastro-intestinal and abdominal wall defects: associated malformations and chromosomal abnormalities. (1992) (119)
- The outcome of twin reversed arterial perfusion sequence diagnosed in the first trimester. (2010) (119)
- Fetal biophysical profile score. VI. Correlation with antepartum umbilical venous fetal pH. (1993) (118)
- Reference range of birth weight with gestation and first‐trimester prediction of small‐for‐gestation neonates (2011) (118)
- Maternal cardiac function in twin pregnancy. (2003) (117)
- Predictive performance of the competing risk model in screening for preeclampsia (2019) (117)
- Ultrasound assessment of cervical length in threatened preterm labor (2003) (117)
- Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia (2009) (117)
- Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial. (2016) (116)
- Maternal Wave Reflections and Arterial Stiffness in Normal Pregnancy as Assessed by Applanation Tonometry (2008) (116)
- Maternal serum free β‐hCG and PAPP‐A in fetal sex chromosome defects in the first trimester (2000) (116)
- What is the most reliable ultrasound parameter for assessment of fetal head descent? (2010) (116)
- Delta‐NT or NT MoM: which is the most appropriate method for calculating accurate patient‐specific risks for trisomy 21 in the first trimester? (2003) (116)
- Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid–base status of growth‐restricted fetuses (2007) (115)
- Prenatal Diagnosis of Gastroschisis: Development of Objective Sonographic Criteria for Predicting Outcome (1993) (114)
- Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness (2008) (114)
- Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. (2002) (114)
- Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11–13 weeks (2011) (114)
- Ultrasound screening for congenital uterine anomalies (1997) (113)
- Fetal lateral cerebral ventriculomegaly: associated malformations and chromosomal defects. (1990) (113)
- Nasal bone length throughout gestation: normal ranges based on 3537 fetal ultrasound measurements (2003) (112)
- Ultrasound markers for fetal chromosomal defects (1996) (111)
- Placental volume measured by three‐dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects (2005) (111)
- Diagnosis of fetal abnormalities at the 10–14‐week scan (1997) (111)
- Screening for trisomies by cell‐free DNA testing of maternal blood: consequences of a failed result (2016) (110)
- Thoraco-amniotic shunting. (1990) (110)
- First-trimester screening for chromosomal abnormalities. (2005) (110)
- Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11+0 to 13+6 weeks of gestation (2008) (110)
- Fetal Nuchal Translucency Thickness at 10–14 Weeks' Gestation and Congenital Diaphragmatic Hernia (1997) (110)
- Performance of screening for aneuploidies by cell‐free DNA analysis of maternal blood in twin pregnancies (2015) (109)
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks' gestation. (2016) (109)
- First‐trimester combined screening for trisomy 21 at 7–14 weeks' gestation (2010) (109)
- Antenatal prediction of lung volume and in-utero treatment by fetal endoscopic tracheal occlusion in severe isolated congenital diaphragmatic hernia. (2009) (108)
- Endothelial Nitric Oxide Synthase Gene Polymorphism and Maternal Vascular Adaptation to Pregnancy (2001) (108)
- Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell‐free DNA test contingent on results from first‐trimester combined test (2016) (108)
- A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free β‐hCG and PAPP‐A (2002) (108)
- Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. (1993) (108)
- Early prenatal diagnosis of triploidy. (1997) (107)
- Birth weight in live births and stillbirths (2016) (107)
- Metabolomics and first-trimester prediction of early-onset preeclampsia (2012) (106)
- Efficacy of Transabdominal Multifetal Pregnancy Reduction: Collaborative Experience Among the World's Largest Centers (1993) (106)
- Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. (2010) (105)
- Fetal plasma erythropoietin concentration in severe growth retardation. (1993) (105)
- Cervical Length at 23 Weeks in Twins in Predicting Spontaneous Preterm Delivery (1999) (105)
- Morphological classification of nuchal skin in human fetuses with trisomy 21, 18, and 13 at 12—18 weeks and in a trisomy 16 mouse (1998) (104)
- Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. (2004) (104)
- Maternal Cardiac Output Between 11 and 13 Weeks of Gestation in the Prediction of Preeclampsia and Small for Gestational Age (2008) (104)
- Doppler studies of the fetal circulation in twin–twin transfusion syndrome (1995) (104)
- Fetal facial defects: associated malformations and chromosomal abnormalities. (1993) (104)
- RELATION OF FETAL HYPOXIA IN GROWTH RETARDATION TO MEAN BLOOD VELOCITY IN THE FETAL AORTA (1986) (104)
- Respiratory function in singleton and twin pregnancy (2002) (103)
- A Comprehensive Analysis of Common Genetic Variation Around Six Candidate Loci for Intrahepatic Cholestasis of Pregnancy (2013) (103)
- Prenatal Detection of Fetal Triploidy from Cell-Free DNA Testing in Maternal Blood (2013) (103)
- Prenatal diagnosis of trisomy 18 at the 10–14‐week ultrasound scan (1997) (102)
- Platelet count in normal, small, and anemic fetuses. (1990) (102)
- Chronic hypertension and adverse pregnancy outcome: a cohort study (2017) (102)
- Fetal Medicine Foundation reference ranges for umbilical artery and middle cerebral artery pulsatility index and cerebroplacental ratio (2019) (102)
- International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome-specific probes and fluorescent in-situ hybridization are used. (1999) (102)
- Collagen Type VI Gene Expression in the Skin of Trisomy 21 Fetuses (1998) (101)
- Fetal renal defects: associated malformations and chromosomal defects. (1992) (101)
- Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6‐week scan: association with chromosomal defects and reproducibility of the method (2006) (101)
- Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts (2001) (101)
- The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities (2000) (101)
- Body stalk anomaly at 10–14 weeks of gestation (1997) (101)
- Screening for trisomies 21, 18 and 13 by cell‐free DNA analysis of maternal blood at 10–11 weeks' gestation and the combined test at 11–13 weeks (2015) (101)
- Uterine artery pulsatility index in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (100)
- Maternal arterial stiffness in pregnancies affected by preeclampsia. (2009) (100)
- Expectant management of missed miscarriage (1998) (100)
- Ultrasonographic estimation of fetal weight: development of new model and assessment of performance of previous models (2018) (100)
- Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. (2006) (100)
- Relation of fetal blood gases and data from computer‐assisted analysis of fetal heart rate patterns in small for gestation fetuses (1991) (100)
- Doppler examination of the middle cerebral artery in anemic fetuses. (1990) (100)
- THE COMPETING RISK APPROACH FOR PREDICTION OF PREECLAMPSIA. (2019) (100)
- Maternal left ventricular mass and diastolic function during pregnancy (2001) (100)
- Fetal loss following ultrasound diagnosis of a live fetus at 6–10 weeks of gestation (2003) (100)
- Antenatal management of fetomaternal alloimmune thrombocytopenia—report of 15 affected pregnancies (1994) (100)
- Prediction of preterm delivery in twins by cervical assessment at 23 weeks (2001) (99)
- Lower genital tract swabs in the prediction of intrauterine infection in preterm prelabour rupture of the membranes (1996) (99)
- Randomized Trial of Fetal Surgery for Severe Left Diaphragmatic Hernia (2021) (99)
- Maternal Plasma Cell-Free Fetal and Maternal DNA at 11-13 Weeks' Gestation: Relation to Fetal and Maternal Characteristics and Pregnancy Outcomes (2013) (99)
- Gestational sac volume measured by three‐dimensional ultrasound at 11 to 13 + 6 weeks of gestation: relation to chromosomal defects (2005) (98)
- Presence of the ‘lemon’ sign in fetuses with spina bifida at the 10–14‐week scan (1997) (98)
- Insulin-like growth factor binding protein-1 (IGFBP-1): a multifunctional role in the human female reproductive tract. (2000) (98)
- Transabdominal versus transcervical and transvaginal multifetal pregnancy reduction: international collaborative experience of more than one thousand cases. (1994) (98)
- First-trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21. (1995) (98)
- First‐trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death (2006) (98)
- Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. (1998) (98)
- Maternal Serum Pregnancy-Associated Plasma Protein a and Fetal Nuchal Translucency Thickness for the Prediction of Fetal Trisomies in Early Pregnancy (1994) (98)
- Contribution of Fetal Tricuspid Regurgitation in First-Trimester Screening for Major Cardiac Defects (2011) (98)
- Maternal cardiac function in normotensive and pre‐eclamptic intrauterine growth restriction (2008) (98)
- Umbilical and fetal middle cerebral artery Doppler at 35–37 weeks' gestation in the prediction of adverse perinatal outcome (2015) (98)
- Cell-Free DNA Analysis for Trisomy Risk Assessment in First-Trimester Twin Pregnancies (2013) (98)
- First-Trimester Screening for Spontaneous Preterm Delivery with Maternal Characteristics and Cervical Length (2012) (97)
- Maternal racial origin and adverse pregnancy outcome: a cohort study (2013) (97)
- Current consequences of prenatal diagnosis of congenital diaphragmatic hernia. (2006) (97)
- Risks of miscarriage and early preterm birth in trichorionic triplet pregnancies with embryo reduction versus expectant management: new data and systematic review. (2006) (97)
- First trimester diagnosis of monoamniotic twin pregnancies (2000) (97)
- Fetal echocardiography at 11–13 weeks by transabdominal high‐frequency ultrasound (2011) (97)
- The 11–13‐week scan: diagnosis and outcome of holoprosencephaly, exomphalos and megacystis (2010) (97)
- Temporal Regulation of the Expression of Syncytin (HERV-W), Maternally Imprinted PEG10, and SGCE in Human Placenta1 (2003) (96)
- Sonographic measurement of cervical length in threatened preterm labor in singleton pregnancies with intact membranes (2005) (96)
- Heart stroke volume and cardiac output by four‐dimensional ultrasound in normal fetuses (2008) (96)
- Antepartum heart rate patterns in small-for-gestational-age third-trimester fetuses: correlations with blood gas values obtained at cordocentesis. (1990) (96)
- CORDOCENTESIS FOR THE DIAGNOSIS AND TREATMENT OF HUMAN FETAL PARVOVIRUS INFECTION (1990) (96)
- Outcome for children born after in utero laser ablation therapy for severe twin‐to‐twin transfusion syndrome (2001) (95)
- Plasma amino acids in appropriate- and small-for-gestational-age fetuses. (1989) (95)
- Fetal middle cerebral artery peak systolic velocity in the investigation of non‐immune hydrops (2004) (94)
- The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy (2004) (94)
- Noninvasive Prenatal Testing for Fetal Trisomies in a Routinely Screened First-Trimester Population (2013) (94)
- Maternal plasma soluble endoglin at 11–13 weeks' gestation in pre‐eclampsia (2010) (93)
- Technical aspects of fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia. (2011) (93)
- Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. (1998) (92)
- Maternal thyroid function at 11 to 13 weeks of gestation and subsequent fetal death. (2010) (92)
- Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta‐analysis of randomized controlled trials using individual patient‐level data (2017) (92)
- Frontomaxillary facial angle in fetuses with trisomy 21 at 11-13(6) weeks. (2007) (92)
- Maternal Uterine Artery Doppler Flow Velocimetry and the Risk of Stillbirth (2007) (92)
- Fetal nuchal oedema: associated malformations and chromosomal defects. (1992) (92)
- Prediction of miscarriage and stillbirth at 11–13 weeks and the contribution of chorionic villus sampling (2011) (91)
- Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta‐analysis of randomized controlled trials using individual patient‐level data (2017) (91)
- The relationship between leptin concentration and bone metabolism in the human fetus. (2000) (91)
- Ultrasound Screening for Spina Bifida: Cranial and Cerebellar Signs in a High‐Risk Population (1987) (91)
- Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta‐analysis (2018) (91)
- Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. (1993) (91)
- Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta‐analysis (2019) (90)
- The influence of medical and psychological interventions on women's distress after miscarriage. (2007) (90)
- The 11-14 week scan. (2000) (90)
- Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks' gestation. (2016) (90)
- Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness (2005) (89)
- Lymphatic vessel hypoplasia in fetuses with Turner syndrome. (1999) (89)
- Learning curve for sonographic examination of the fetal nasal bone at 11–14 weeks (2003) (89)
- Fetal choroid plexus cysts and trisomy 18: Assessment of risk based on ultrasound findings and maternal age (1994) (88)
- Maternal and foetal angiogenic imbalance in congenital heart defects. (2014) (88)
- Levels of C‐reactive protein in pregnant women who subsequently develop pre‐eclampsia (2002) (88)
- Outcome of antenatally diagnosed sacrococcygeal teratomas: single-center experience (1993-2004). (2006) (88)
- Effects of intrauterine growth retardation on postnatal visceral and cerebral blood flow velocity. (1991) (88)
- First-trimester maternal plasma cell-free fetal DNA and preeclampsia. (2009) (88)
- Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum (2015) (88)
- Relation of rate of urine production to oxygen tension in small-for-gestational-age fetuses. (1990) (87)
- Cervical assessment at the routine 23‐weeks' scan: problems with transabdominal sonography (2000) (87)
- Normal reference ranges for biochemical substances relating to renal, hepatic, and bone function in fetal and maternal plasma throughout pregnancy. (1985) (86)
- Prediction of fetal anemia in rhesus disease by measurement of fetal middle cerebral artery peak systolic velocity (2004) (86)
- Elective cerclage vs. ultrasound‐indicated cerclage in high‐risk pregnancies (2002) (86)
- Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies (2015) (86)
- Parathyroid hormone-related peptide in normal human fetal development. (1990) (86)
- Accuracy of first‐trimester combined test in screening for trisomies 21, 18 and 13 (2017) (85)
- Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy (1995) (85)
- Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks (2008) (85)
- The pathophysiology of the insulin‐like growth factor axis in fetal growth failure: a basis for programming by undernutrition? (1994) (84)
- Prenatal Diagnosis of Triploidy During the Second Trimester of Pregnancy (1996) (84)
- Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. (1992) (84)
- Assessment of Fetal Sex Chromosome Aneuploidy Using Directed Cell-Free DNA Analysis (2013) (84)
- Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus. (2011) (83)
- Maternal cardiac function and uterine artery Doppler at 11–14 weeks in the prediction of pre‐eclampsia in nulliparous women (2008) (83)
- Fetal Surgery for Congenital Diaphragmatic Hernia Is Back from Never Gone (2011) (83)
- Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. (2005) (83)
- Cystic Hygromas, Nuchal Edema, and Nuchal Translucency at 11–14 Weeks of Gestation (2006) (83)
- The implementation of first‐trimester scanning at 10–13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units (1995) (83)
- Fetal heart rate in chromosomally abnormal fetuses (2000) (83)
- Prenatal diagnosis, prediction of outcome and in utero therapy of isolated congenital diaphragmatic hernia (2008) (83)
- Cordocentesis in the investigation of fetal erythropoiesis. (1989) (82)
- Prediction and prevention of small‐for‐gestational‐age neonates: evidence from SPREE and ASPRE (2018) (82)
- Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. (2006) (82)
- Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy. (2007) (82)
- Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β‐hCG and PAPP‐A at 11 + 0 to 13 + 6 weeks (2006) (82)
- Prevention of preeclampsia with aspirin. (2020) (81)
- Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation (1996) (81)
- Fetal nuchal cystic hygromata: associated malformations and chromosomal defects. (1991) (81)
- An expanded role for heterozygous mutations of ABCB4, ABCB11, ATP8B1, ABCC2 and TJP2 in intrahepatic cholestasis of pregnancy (2017) (81)
- First-trimester metabolomic detection of late-onset preeclampsia. (2013) (81)
- Haemophilia: strategies for carrier detection and prenatal diagnosis. (1993) (81)
- Umbilical Cord Cysts in Early Pregnancy (1997) (81)
- Hypertensive Disorders in Pregnancy: Screening by Systolic Diastolic and Mean Arterial Pressure at 11–13 Weeks (2011) (80)
- Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (80)
- Thyroid Function in Small for Gestational Age Fetuses (1991) (80)
- Screening for trisomy 21 in twin pregnancies in the first trimester: an update of the impact of chorionicity on maternal serum markers (2008) (80)
- Three‐dimensional sonographic description of the fetal frontal bones and metopic suture (2005) (80)
- Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies. (2000) (80)
- Contribution of Ductus Venosus Doppler in First-Trimester Screening for Major Cardiac Defects (2010) (80)
- Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation. (1995) (80)
- Intertwin Disparity in Fetal Size in Monochorionic and Dichorionic Pregnancies (1998) (80)
- Aspirin for Evidence‐Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit (2018) (79)
- Predictors of neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetoscopic tracheal occlusion (2013) (79)
- Artery-to-artery anastomosis in monochorionic twins. (1994) (79)
- Cervical length at 22–24 weeks of gestation: comparison of transvaginal and transperineal‐translabial ultrasonography (2001) (79)
- Twin-twin transfusion syndrome during the 2nd trimester is associated with small intertwin hemoglobin differences. (1991) (79)
- Prediction of spontaneous preterm delivery from endocervical length at 11 to 13 weeks (2011) (79)
- The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. (1985) (79)
- Placental Volume at 11–13 Weeks’ Gestation in the Prediction of Birth Weight Percentile (2011) (79)
- Pre‐induction sonographic measurement of cervical length in prolonged pregnancy: the effect of parity in the prediction of induction‐to‐delivery interval (2003) (78)
- Investigation of the cause of miscarriage and its influence on women's psychological distress (1999) (78)
- Duration of persistent abnormal ductus venosus flow and its impact on perinatal outcome in fetal growth restriction (2011) (78)
- Individualized Risk Assessment for Adverse Pregnancy Outcome by Uterine Artery Doppler at 23 Weeks (2001) (78)
- Color Doppler imaging of the uterine artery in pregnancy: normal ranges of impedance to blood flow, mean velocity and volume of flow (1992) (78)
- Prevention of pre‐eclampsia by low‐molecular‐weight heparin in addition to aspirin: a meta‐analysis (2016) (78)
- Low‐dose aspirin for prevention of adverse outcomes related to abnormal placentation (2014) (77)
- Hidden high rate of pre‐eclampsia in twin compared with singleton pregnancy (2017) (77)
- Models for the prediction of successful induction of labor based on pre-induction sonographic measurement of cervical length (2005) (77)
- Lethal congenital arthrogryposis presents with increased nuchal translucency at 10–14 weeks of gestation (1997) (77)
- Successful outcome after Nd : YAG laser separation of chorioangiopagus‐twins under sonoendoscopic control (1992) (77)
- Single umbilical artery at 11–14 weeks' gestation: relation to chromosomal defects (2003) (77)
- Doppler study of uterine artery blood flow: comparison of findings in the first and second trimesters of pregnancy. (1991) (77)
- Learning curve for Doppler assessment of ductus venosus flow at 11 + 0 to 13 + 6 weeks' gestation (2008) (77)
- Prenatal diagnosis for severe inherited skin disorders: 25 years' experience (2006) (77)
- Maternal serum inhibin‐A and activin‐A levels in the first trimester of pregnancies developing pre‐eclampsia (2008) (76)
- International, Collaborative Experience of 1789 Patients Having Multifetal Pregnancy Reduction: A Plateauing of Risks and Outcomes (1995) (76)
- Diagnosis of Fetal Abnormalities : The 18-23-Week Scan (1999) (76)
- Diagnosis of the Meckel-Gruber syndrome at eleven to fourteen weeks' gestation. (1997) (76)
- Fetal urine biochemistry in the assessment of obstructive uropathy. (1992) (75)
- Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment (1992) (75)
- Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study (2006) (75)
- Doppler dynamics and their complex interrelation with fetal oxygen pressure, carbon dioxide pressure, and pH in growth‐retarded fetuses (1994) (75)
- Contribution of the myocardial performance index and aortic isthmus blood flow index to predicting mortality in preterm growth‐restricted fetuses (2009) (75)
- The prevalence of non‐viable pregnancy at 10–13 weeks of gestation (1996) (74)
- Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10–14 weeks of gestation (1996) (74)
- Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11–14 weeks of gestation (2002) (74)
- Prediction of fetal anemia by measurement of the mean blood velocity in the fetal aorta. (1990) (74)
- Non‐invasive assessment of endothelial function in normal pregnancy (2000) (74)
- WHY CONFINE CHORIONIC VILLUS (PLACENTAL) BIOPSY TO THE FIRST TRIMESTER? (1986) (74)
- Competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 35–37 weeks' gestation (2016) (74)
- Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. (1999) (73)
- Successful induction of labor: prediction by preinduction cervical length, angle of progression and cervical elastography (2014) (73)
- Ductus Venosus in the First Trimester: Contribution to Screening of Chromosomal, Cardiac Defects and Monochorionic Twin Complications (2010) (73)
- Placental Expression of Interferon-γ (IFN-γ) and Its Receptor IFN-γR2 Fail to Switch from Early Hypoxic to Late Normotensive Development in Preeclampsia (2005) (73)
- FETAL BREATHING MOVEMENTS AS PREDICTOR OF FAVOURABLE PREGNANCY OUTCOME AFTER OLIGOHYDRAMNIOS DUE TO MEMBRANE RUPTURE IN SECOND TRIMESTER (1987) (73)
- Assessment of umbilical arterial and venous flow using color Doppler (1999) (73)
- Aberrant right subclavian artery at 16 to 23 + 6 weeks of gestation: a marker for chromosomal abnormality (2010) (73)
- Detecting open spina bifida at the 11–13‐week scan by assessing intracranial translucency and the posterior brain region: mid‐sagittal or axial plane? (2011) (73)
- First-Trimester Maternal Serum a Disintegrin and Metalloprotease 12 (ADAM12) and Adverse Pregnancy Outcome (2008) (73)
- Lung‐to‐head ratio: a need to unify the technique (2012) (72)
- First‐Trimester Maternal Serum Levels of Placenta Growth Factor as Predictor of Preeclampsia and Fetal Growth Restriction (2001) (72)
- Ultrasonographically detectable markers of fetal chromosomal defects (1993) (72)
- Sonographic measurement of cervical length in twin pregnancies in threatened preterm labor (2004) (71)
- Prenatal diagnosis of congenital diaphragmatic hernia: associated malformations and chromosomal defects. (1989) (71)
- Changing perspectives on the perinatal management of isolated congenital diaphragmatic hernia in Europe. (2009) (71)
- Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. (2010) (71)
- Labor: an immunologically beneficial process for the neonate. (1994) (71)
- Plasma amino acids in appropriate‐ and small‐for‐gestational‐age fetuses (1990) (71)
- Prospective first‐trimester screening for trisomies by cell‐free DNA testing of maternal blood in twin pregnancy (2016) (70)
- Predictors of necrotizing enterocolitis in preterm growth-restricted neonates. (2008) (70)
- Outcome of antenatally diagnosed talipes equinovarus in an unselected obstetric population (2002) (70)
- Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. (2000) (70)
- One stop clinic for assessment of risk for fetal anomalies: a report of the first year of prospective screening for chromosomal anomalies in the first trimester. (2001) (70)
- Normal Ranges of Embryonic Length, Embryonic Heart Rate, Gestational Sac Diameter and Yolk Sac Diameter at 6–10 Weeks (2010) (70)
- Cardiac Gene Expression of Atrial Natriuretic Peptide and Brain Natriuretic Peptide in Trisomic Fetuses (1996) (70)
- Vaginal micronized progesterone and risk of preterm delivery in high‐risk twin pregnancies: secondary analysis of a placebo‐controlled randomized trial and meta‐analysis (2011) (69)
- Maternal Arterial Stiffness in Women Who Subsequently Develop Pre-Eclampsia (2011) (69)
- Cervical cerclage for prevention of preterm delivery in women with short cervix (2004) (69)
- Ductus Venosus Doppler at 11 to 13 Weeks of Gestation in the Prediction of Outcome in Twin Pregnancies (2009) (69)
- Early ultrasound diagnosis and follow‐up of molar pregnancies (1997) (69)
- Maternal hemodynamics at 11–13 weeks' gestation and risk of pre‐eclampsia (2012) (69)
- Ultrasonographic occiput position in early labour in the prediction of caesarean section (2004) (68)
- A SINGLE-OPERATOR TECHNIQUE FOR FIRST-TRIMESTER CHORION BIOPSY (1983) (68)
- Blood leucocyte count in the human fetus. (1992) (68)
- Timing of lung size assessment in the prediction of survival in fetuses with diaphragmatic hernia (2008) (68)
- Psychological outcomes following missed abortions and provision of follow‐up care (1998) (68)
- Transvaginal ultrasound in pregnancy: its acceptability to women and maternal psychological morbidity (2003) (68)
- Fetal RHD genotype detection from circulating cell‐free fetal DNA in maternal plasma in non‐sensitized RhD negative women (2011) (68)
- Prediction of small‐for‐gestational‐age neonates: screening by fetal biometry at 35–37 weeks (2015) (68)
- Ultrasonographic prediction of early miscarriage. (2011) (68)
- Two‐stage first‐trimester screening for trisomy 21 by ultrasound assessment and biochemical testing (2010) (68)
- First-Trimester Prediction of Macrosomia (2010) (68)
- Evolution of the lambda or twin-chorionic peak sign in dichorionic twin pregnancies (1997) (68)
- Three‐dimensional sonographic calculation of the volume of intracranial structures in growth‐restricted and appropriate‐for‐gestational age fetuses (2009) (67)
- Prenatal Determination of Chorionicity in Triplet Pregnancy by Ultrasonographic Examination of the Ipsilon Zone (1996) (67)
- Maternal plasma inhibin A at 11–13 weeks of gestation in hypertensive disorders of pregnancy (2009) (67)
- Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years (1997) (67)
- Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. (2000) (67)
- Increased nuchal translucency in trisomy 21 fetuses: relationship to narrowing of the aortic isthmus. (1995) (67)
- Frontomaxillary facial angle in fetuses with spina bifida at 11–13 weeks' gestation (2010) (67)
- Umbilical and fetal middle cerebral artery Doppler at 30–34 weeks' gestation in the prediction of adverse perinatal outcome (2015) (67)
- How to record uterine artery Doppler in the first trimester (2013) (67)
- Prevention of Perinatal Death and Adverse Perinatal Outcome Using Low-Dose Aspirin: A Meta-Analysis (2013) (66)
- Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. (1995) (66)
- Assessment of lung area in fetuses with congenital diaphragmatic hernia (2007) (66)
- Screening for pre‐eclampsia and fetal growth restriction in twin pregnancies at 23 weeks of gestation by transvaginal uterine artery Doppler (2002) (66)
- Reference ranges for tissue Doppler measures of maternal systolic and diastolic left ventricular function (2007) (66)
- Maternal plasma soluble fms‐like tyrosine kinase‐1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia (2010) (66)
- Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ Gestation (2012) (66)
- Prenasal thickness in trisomy‐21 fetuses at 16–24 weeks of gestation (2008) (65)
- Three‐dimensional sonography of the posterior fossa in fetuses with open spina bifida at 11–13 weeks' gestation (2011) (65)
- Ultrasound examination at 37 weeks' gestation in the prediction of pregnancy outcome: the value of cervical assessment (2003) (65)
- Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies. (1999) (65)
- Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor (2006) (65)
- Current outcome of antenatally diagnosed exomphalos: an 11 year review. (2006) (65)
- Fetal lung volume after endoscopic tracheal occlusion in the prediction of postnatal outcome. (2008) (65)
- Maxillary length at 11–14 weeks of gestation in fetuses with trisomy 21 (2004) (65)
- Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation (2008) (65)
- Fully automated, real-time 3D ultrasound segmentation to estimate first trimester placental volume using deep learning. (2018) (65)
- Prediction of small‐for‐gestational‐age neonates: screening by fetal biometry at 30–34 weeks (2015) (64)
- First trimester maternal serum pregnancy‐associated plasma protein A and pregnancy‐specific βl‐glycoprotein in fetal trisomies (1994) (64)
- Pre‐induction sonographic measurement of cervical length in prolonged pregnancy: the effect of parity in the prediction of the need for Cesarean section (2003) (64)
- First‐trimester maternal serum matrix metalloproteinase‐9 (MMP‐9) and adverse pregnancy outcome (2009) (64)
- Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions. (1993) (64)
- Fetal Acidosis and Hyperlacticaemia Diagnosed by Cordocentesis in Pregnancies Complicated by Maternal Diabetes Mellitus (1991) (64)
- Body Mass Index at 11–13 Weeks’ Gestation and Pregnancy Complications (2011) (63)
- Screening for Adverse Pregnancy Outcome by Ductus Venosus Doppler at 11–13+6 Weeks of Gestation (2008) (63)
- Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. (2000) (63)
- Maternal cardiac function in fetal growth‐restricted and non‐growth‐restricted small‐for‐gestational age pregnancies (2007) (62)
- A reassessment of biochemical marker distributions in trisomy 21‐affected and unaffected twin pregnancies in the first trimester (2011) (62)
- First-Trimester Contingent Screening for Trisomies 21, 18 and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing (2013) (62)
- Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation. (2019) (62)
- First-Trimester Screening for Gestational Diabetes Mellitus Based on Maternal Characteristics and History (2014) (62)
- Closed gastroschisis: Antenatal and postnatal features. (2001) (62)
- Prediction of outcome in isolated congenital diaphragmatic hernia and its consequences for fetal therapy. (2008) (62)
- Comparison of fetal lung area to head circumference ratio with lung volume in the prediction of postnatal outcome in diaphragmatic hernia (2007) (62)
- Fetal trunk and head volume measured by three‐dimensional ultrasound at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal pregnancies (2005) (62)
- Relationship between lung‐to‐head ratio and lung volume in normal fetuses and fetuses with diaphragmatic hernia (2006) (61)
- Twin chorionicity and pre‐eclampsia (2001) (61)
- Doppler investigation of the fetal circulation (1991) (61)
- Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. (1995) (61)
- Erythroblastosis and reticulocytosis in anemic fetuses. (1988) (61)
- Validation of metabolomic models for prediction of early-onset preeclampsia. (2015) (61)
- Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial (2007) (61)
- Fetal exomphalos and chromosomal defects: relationship to maternal age and gestation (1995) (60)
- Ultrasound in Labor and Delivery (2010) (60)
- Replacing the Combined Test by Cell-Free DNA Testing in Screening for Trisomies 21, 18 and 13: Impact on the Diagnosis of Other Chromosomal Abnormalities (2014) (60)
- Three‐dimensional sonographic description of abnormal metopic suture in second‐ and third‐trimester fetuses (2005) (60)
- Randomized Trial of Fetal Surgery for Moderate Left Diaphragmatic Hernia (2021) (60)
- The influence of maternal insulin‐dependent diabetes on fetal nuchal translucency thickness and first‐trimester maternal serum biochemical markers of aneuploidy (2005) (60)
- Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia (2010) (60)
- Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization. (1988) (60)
- Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free β‐hCG and fetal nuchal translucency thickness (1995) (60)
- Fetoscopy and fetal tissue sampling. (1983) (60)
- Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester. (2001) (60)
- Placental and fetal Doppler velocimetry in pregnancies complicated by maternal diabetes mellitus. (1993) (60)
- Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE) (2016) (60)
- The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β‐hCG and PAPP‐A at 10–14 weeks of gestation (2000) (59)
- Metopic suture in fetuses with Apert syndrome at 22–27 weeks of gestation (2005) (59)
- Single uterine entry for genetic amniocentesis in twin pregnancies (1996) (59)
- In vivo assessment of the biomechanical properties of the uterine cervix in pregnancy (2014) (58)
- Optimal Method and Timing of Intrauterine Intervention in Twin Reversed Arterial Perfusion Sequence: Case Study and Meta-Analysis (2014) (58)
- Correlation of ultrasound and pathologic findings of placental anomalies in pregnancies with elevated maternal serum alpha-fetoprotein. (1990) (58)
- Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery (2000) (58)
- A unified approach to risk assessment for fetal aneuploidies (2015) (58)
- Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancy. (1987) (58)
- Prediction of fetal acidaemia in pregnancies complicated by maternal diabetes mellitus by biophysical profile scoring and fetal heart rate monitoring (1993) (58)
- Fetal Growth Restriction and Postnatal Development (2006) (58)
- Raised maternal serum inhibin A concentration at 10 to 14 weeks of gestation is associated with pre‐eclampsia (2000) (58)
- Fetal heart defects: potential and pitfalls of first-trimester detection. (2013) (58)
- Preterm birth: the value of sonographic measurement of cervical length (2006) (58)
- Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight. (1993) (58)
- Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21 (2009) (58)
- Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype (2005) (58)
- Aberrant right subclavian artery at 11 + 0 to 13 + 6 weeks of gestation in chromosomally normal and abnormal fetuses (2008) (58)
- Placental villus morphology in relation to maternal hypoxia at high altitude. (2001) (58)
- Autonomic Neuropathy and Diabetic Foot Ulceration (1986) (57)
- Intrapartum sonography to determine fetal occipital position: interobserver agreement (2004) (57)
- Fetoscopic endoluminal tracheal occlusion and reestablishment of fetal airways for congenital diaphragmatic hernia (2018) (57)
- Definitive surgical management of antenatally diagnosed exomphalos. (2005) (57)
- Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness (1996) (57)
- Cervical length at mid-pregnancy and the risk of primary cesarean delivery. (2008) (57)
- Meta‐analysis on the effect of aspirin use for prevention of preeclampsia on placental abruption and antepartum hemorrhage (2018) (57)
- Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. (2019) (57)
- Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation (2014) (56)
- Blood Gases and Acid‐Base Status of the Human Second‐Trimester Fetus (1986) (56)
- Screening for morbidly adherent placenta in early pregnancy (2018) (56)
- Mass spectrometric discovery and selective reaction monitoring (SRM) of putative protein biomarker candidates in first trimester Trisomy 21 maternal serum. (2011) (56)
- Maxillary gap at 11–13 weeks' gestation: marker of cleft lip and palate (2015) (56)
- Platelet changes and subsequent development of pre‐eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening (2002) (56)
- Asymmetric dimethylarginine, arginine and homoarginine at 11–13 weeks’ gestation and preeclampsia: a case–control study (2013) (56)
- Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis (2006) (56)
- Serum CA125 at 11–14 weeks of gestation in women with morphologically normal ovaries (2000) (56)
- Effects of intravascular fetal blood transfusion on fetal intracardiac Doppler velocity waveforms. (1990) (56)
- Natural history of trisomy 21 fetuses with increased nuchal translucency thickness (1995) (55)
- Cerebral ventricular system in fetuses with open spina bifida at 11–13 weeks' gestation (2012) (55)
- First trimester fetal nuchal translucency (1995) (55)
- Human fetal sympathoadrenal responsiveness. (1990) (55)
- Prediction of small‐for‐gestational‐age neonates: screening by biophysical and biochemical markers at 19–24 weeks (2015) (55)
- Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery (2012) (55)
- Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks (2008) (55)
- First trimester aneuploidy screening in the presence of a vanishing twin: implications for maternal serum markers (2010) (54)
- Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length (2007) (54)
- Relationship of fetal biophysical profile and blood gas values at cordocentesis in severely growth-retarded fetuses. (1990) (54)
- Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation. (2007) (54)
- Is high fetal nuchal translucency associated with submicroscopic chromosomal abnormalities on array CGH? (2014) (54)
- Essential fatty acid status of fetal plasma phospholipids: similar to postnatal values obtained at comparable gestational ages. (1996) (54)
- ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm (2018) (54)
- Fetal arterial Doppler studies in twin‐twin transfusion syndrome. (1995) (54)
- Fetal Fraction Estimate in Twin Pregnancies Using Directed Cell-Free DNA Analysis (2013) (54)
- Subpopulations of CD34‐positive haemopoietic progenitors in fetal blood (1994) (54)
- Fetal T-lymphocyte subpopulations in normal pregnancies. (1992) (53)
- Maternal cardiac function in fetal growth restriction (2006) (53)
- Endoscopic Placental Laser Coagulation in Monochorionic Diamniotic Twins with Type II Selective Fetal Growth Restriction (2015) (53)
- Evolution of the Lambda or Twin‐Chorionic Peak Sign in Dichorionic Twin Pregnancies (1997) (52)
- Biophysical and biochemical markers at 30–34 weeks' gestation in the prediction of adverse perinatal outcome (2016) (52)
- Assessment of the fetal nasal bone at 11–14 weeks of gestation by three‐dimensional ultrasound (2004) (52)
- Twin-to-twin transfusion syndrome--debates on the etiology, natural history and management. (2000) (52)
- A robust second‐generation genome‐wide test for fetal aneuploidy based on shotgun sequencing cell‐free DNA in maternal blood (2013) (52)
- Fetal RHD Genotyping in Maternal Plasma at 11–13 Weeks of Gestation (2011) (52)
- Biophysical and biochemical markers at 35–37 weeks' gestation in the prediction of adverse perinatal outcome (2016) (52)
- Semi‐automated system for measurement of nuchal translucency thickness (2010) (52)
- Frontomaxillary facial angle in chromosomally normal fetuses at 11 + 0 to 13 + 6 weeks (2007) (51)
- Immune and Non‐immune Hydrops (1986) (51)
- Cardiac defects in 1st-trimester fetuses with trisomy 18. (1995) (51)
- Serum soluble fms‐like tyrosine kinase‐1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (51)
- Trichorionic and Dichorionic Triplet Pregnancies at 10-14 Weeks: Outcome after Embryo Reduction Compared to Expectant Management (2013) (51)
- Cervical length at 23 weeks in triplets: prediction of spontaneous preterm delivery (2000) (51)
- Screening for pre‐eclampsia at 35–37 weeks' gestation (2018) (51)
- Detection of sex chromosome abnormalities by nuchal translucency screening at 10–14 weeks (1998) (51)
- Maternal serum vitamin D levels at 11–13 weeks of gestation in preeclampsia (2013) (51)
- Aspirin delays the development of preeclampsia. (2019) (51)
- Current controversies in prenatal diagnosis 4: Should fetal surgery be done in all cases of severe diaphragmatic hernia? (2009) (51)
- Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness. (1996) (51)
- Isolated single umbilical artery and fetal karyotype (2010) (50)
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. (2018) (50)
- Prevalence and Outcome of Absence of Ductus Venosus at 11+0 to 13+6 Weeks (2011) (50)
- Impaired respiratory function in infants with anterior abdominal wall defects. (1993) (50)
- Maternal left ventricular transverse and long‐axis systolic function during pregnancy (2001) (50)
- Is early delivery beneficial in gastroschisis? (2013) (50)
- Longitudinal changes in uterine artery Doppler and blood pressure and risk of pre‐eclampsia (2014) (50)
- Management of twin pregnancies discordant for anencephaly (1997) (50)
- Fetal trunk and head volume in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation (2005) (49)
- First‐trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell‐free DNA testing (2015) (49)
- First trimester maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein A in pregnancies complicated by diabetes mellitus (2012) (49)
- Fetal pancreatic beta-cell function in pregnancies complicated by maternal diabetes mellitus: relationship to fetal acidemia and macrosomia. (1993) (49)
- Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks' gestation—reproducibility of measurements (2007) (49)
- Second-Trimester Uterine Artery Doppler in the Prediction of Stillbirths (2012) (49)
- Cordocentesis in the diagnosis of intrauterine starvation. (1989) (49)
- Congenital bacterial sepsis in very preterm infants. (1992) (48)
- CHRONIC DRAINAGE OF FETAL PULMONARY CYST (1987) (48)
- Screening for triploidy by the risk algorithms for trisomies 21, 18 and 13 at 11 weeks to 13 weeks and 6 days of gestation (2008) (48)
- Frontomaxillary facial angle in trisomy 21 fetuses at 16–24 weeks of gestation (2008) (48)
- Fetal holoprosencephaly: associated malformations and chromosomal defects. (1990) (48)
- Serum pregnancy‐associated plasma protein‐A in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (48)
- Utero-placental blood velocity resistance index and umbilical venous pO2, pCO2, pH, lactate and erythroblast count in growth-retarded fetuses. (1986) (47)
- Comparison of chorion villus sampling and early amniocentesis for karyotyping in 1,492 singleton pregnancies. (1996) (47)
- Automatic 3D ultrasound segmentation of the first trimester placenta using deep learning (2017) (47)
- Preterm prelabour amniorrhexis: intrauterine infection and interval between membrane rupture and delivery. (1995) (47)
- Maternal serum biochemistry at 11–13+6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening (2005) (47)
- Metabolomic analysis for first-trimester Down syndrome prediction. (2013) (47)
- Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation. (2006) (47)
- PRENATAL DIAGNOSIS OF GLANZMANN'S THROMBASTHENIA (1985) (46)
- Fetal polycythemia and thrombocytopenia in pregnancies complicated by maternal diabetes mellitus. (1992) (46)
- Prediction of large‐for‐gestational‐age neonates: screening by maternal factors and biomarkers in the three trimesters of pregnancy (2016) (46)
- Chronic hypertension: first‐trimester blood pressure control and likelihood of severe hypertension, preeclampsia, and small for gestational age (2018) (46)
- Maternal plasma cell‐free DNA in the prediction of pre‐eclampsia (2015) (46)
- Cervical screening for preterm delivery (2002) (46)
- Aspirin for Evidence‐Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia (2017) (45)
- First-trimester biochemical markers of placentation in screening for gestational diabetes mellitus. (2015) (45)
- Cervical length and maternal factors in expectantly managed prolonged pregnancy: prediction of onset of labor and mode of delivery (2008) (45)
- Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency (1996) (45)
- Umbilical venous pressure in normal, growth-retarded, and anemic fetuses. (1994) (45)
- Maternal serum placental growth factor at 11–13 weeks in chromosomally abnormal pregnancies (2009) (45)
- Sonographic markers of fetal aneuploidy--a review. (2003) (44)
- Plasma prostanoids in pregnancy‐induced hypertension (1982) (44)
- Assessment of the gap between the fetal nasal bones at 11 to 13 + 6 weeks of gestation by three‐dimensional ultrasound (2005) (44)
- Prediction of stillbirth from maternal demographic and pregnancy characteristics (2016) (44)
- Normal blood cell values in the early mid‐trimester fetus (1985) (44)
- Criteria for Screening and Diagnosis of Gestational Diabetes Mellitus in the First Trimester of Pregnancy (2011) (44)
- Value of routine ultrasound examination at 35–37 weeks' gestation in diagnosis of fetal abnormalities (2020) (44)
- The effect of gestational age and cervical length measurements in the prediction of spontaneous preterm birth in twin pregnancies: an individual patient level meta‐analysis (2016) (44)
- Management of Fetal Alloimmune Thrombocytopenia by Weekly in utero Platelet Transfusions (1990) (43)
- Fetal oxygenation at cordocentesis, maternal smoking and childhood neuro-development. (1995) (43)
- ASPRE trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia (2017) (43)
- Fetal sex determination using circulating cell‐free fetal DNA (ccffDNA) at 11 to 13 weeks of gestation (2010) (43)
- First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. (2016) (43)
- Urine albumin concentration and albumin‐to‐creatinine ratio at 11+0 to 13+6 weeks in the prediction of pre‐eclampsia (2008) (43)
- Cervical cerclage for preterm birth prevention in twin gestation with short cervix: a retrospective cohort study (2016) (43)
- Frontomaxillary and mandibulomaxillary facial angles at 11 + 0 to 13 + 6 weeks in fetuses with trisomy 18 (2007) (43)
- Preterm delivery and growth restriction in multifetal pregnancies reduced to twins. (1997) (43)
- Fetoscopy in the assessment of unexplained fetal hydrops (1985) (43)
- Color Doppler ultrasonography in the identification of communicating vessels in twin‐twin transfusion syndrome and acardiac twins. (1995) (43)
- Maternal Thyroid Function at 11–13 Weeks of Gestation (2010) (43)
- Sonographic measurement of cervical length in preterm prelabor amniorrhexis (2004) (43)
- First‐trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure (2019) (42)
- Prenatal diagnosis of an extensive fetal lymphangioma using ultrasonography, magnetic resonance imaging and cytology. (1997) (42)
- Longitudinal changes in maternal hemodynamics in a population at risk for pre‐eclampsia (2014) (42)
- Prediction of small‐for‐gestational‐age neonates: screening by biophysical and biochemical markers at 30–34 weeks (2015) (42)
- Prediction of imminent preeclampsia at 35-37 weeks gestation. (2019) (42)
- Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia (2011) (42)
- Angiotensin II type 1 and 2 receptors gene polymorphisms in pre‐eclampsia and normal pregnancy in three different populations (2009) (42)
- Placental expression of interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. (2005) (42)
- Early Detection of Preeclampsia Using Circulating Small non-coding RNA (2018) (42)
- Pleuroamniotic shunting for decompression of fetal pleural effusions. (1988) (42)
- Outcome of Pregnancy in Patients with Insulin‐depedent Diabetes Mellitus and Nephropathy with Moderate Renal Impairment (1996) (42)
- Inter‐twin membrane folding in monochorionic pregnancies (1998) (42)
- Nuchal translucency measurements for first-trimester screening: the 'price' of inaccuracy. (2007) (42)
- Erratum to “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre‐eclampsia: A pragmatic guide for first‐trimester screening and prevention” [Int J Gynecol Obstet 145 Suppl. 1 (2019) 1–33] (2019) (41)
- Prediction of Preeclampsia by Mean Arterial Pressure at 11-13 and 20-24 Weeks' Gestation (2014) (41)
- CERVICAL PESSARY TO PREVENT PRETERM BIRTH IN ASYMPTOMATIC HIGH-RISK WOMEN: A SYSTEMATIC REVIEW AND META-ANALYSIS. (2020) (41)
- Metabolomic prediction of fetal congenital heart defect in the first trimester. (2014) (41)
- Maternal plasma pentraxin 3 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy (2009) (41)
- Outcome of CDH infants following fetoscopic tracheal occlusion - influence of premature delivery. (2013) (41)
- Uterine Artery Doppler at 30-33 Weeks' Gestation in the Prediction of Preeclampsia (2013) (41)
- Fetal exomphalos at 11 to 14 weeks of gestation. (1995) (41)
- Screening for fetal chromosomal abnormalities: need to change the rules (1994) (41)
- First-Trimester Uterine Artery Doppler and Serum Pregnancy-Associated Plasma Protein-A in Preeclampsia and Chromosomal Defects (2009) (41)
- Paternally Expressed, Imprinted Insulin-Like Growth Factor-2 in Chorionic Villi Correlates Significantly with Birth Weight (2013) (41)
- Prediction of fetal acidaemia in intrauterine growth retardation: comparison of quantified fetal activity with biophysical profile score (1993) (41)
- Evaluation of human chorionic gonadotropin beta-subunit mRNA concentrations in maternal serum in aneuploid pregnancies: a feasibility study. (2004) (40)
- Contribution of Method of Conception on Pregnancy Outcome after the 11–13 Weeks Scan (2011) (40)
- Fetal intraventricular haemorrhage and maternal warfarin (1993) (40)
- Epigenetic-Genetic Chromosome Dosage Approach for Fetal Trisomy 21 Detection Using an Autosomal Genetic Reference Marker (2010) (40)
- Atrial natriuretic factor concentration in normal, growth-retarded, anemic, and hydropic fetuses. (1994) (40)
- Maternal serum placental growth factor at 11–13 weeks' gestation and fetal cardiac defects (2013) (40)
- Fetal biochemistry in growth retardation. (1992) (40)
- First-Trimester Screening for Neural Tube Defects Using Alpha-Fetoprotein (2012) (40)
- UK NHS pilot study on cell‐free DNA testing in screening for fetal trisomies: factors affecting uptake (2015) (40)
- Imaging single DNA molecules for high precision NIPT (2018) (40)
- Association of placental volume measured by MRI and birth weight percentile (2011) (39)
- ATTEMPTED BONE-MARROW TRANSPLANTATION IN A 17-WEEK FETUS (1986) (39)
- Uterine artery Doppler in the investigatioin of pregnancies with raised maternal serum alphafetoprotein (1990) (39)
- Maternal Serum Activin A at 11–13 Weeks of Gestation in Hypertensive Disorders of Pregnancy (2009) (39)
- Prediction of small‐for‐gestational‐age neonates: screening by uterine artery Doppler and mean arterial pressure at 35–37 weeks (2015) (39)
- Small for gestational age (1999) (39)
- Comparison of color Doppler uterine artery indices in a population at high risk for adverse outcome at 24 weeks' gestation (2003) (39)
- Diagnosis of major heart defects by routine first‐trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus (2019) (39)
- Increased fetal nuchal translucency thickness at 10–14 weeks: is screening for maternal–fetal infection necessary? (1997) (39)
- Glucose metabolism in pregnancy at high altitude. (2001) (39)
- The influence of parity and gravidity on first trimester markers of chromosomal abnormality (2000) (39)
- FETAL BLOOD SAMPLING IN INVESTIGATION OF CHROMOSOME MOSAICISM IN AMNIOTIC FLUID CELL CULTURE (1988) (38)
- Metabolomic determination of pathogenesis of late-onset preeclampsia (2017) (38)
- The impact of fetal gender on first trimester nuchal translucency and maternal serum free β‐hCG and PAPP‐A MoM in normal and trisomy 21 pregnancies (2009) (38)
- First Trimester Sex Hormone-Binding Globulin and Subsequent Development of Preeclampsia or Other Adverse Pregnancy Outcomes (2005) (38)
- Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus. (2009) (38)
- Doppler Studies in Red Cell Isoimmunization (1989) (38)
- Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A (2008) (38)
- Dose dependency between cigarette consumption and reduced maternal serum PAPP‐A levels at 11–13+6 weeks of gestation (2007) (38)
- Plasma atrial natriuretic peptide in human fetus: response to intravascular blood transfusion. (1989) (38)
- A Mixture Model of Ductus Venosus Pulsatility Index in Screening for Aneuploidies at 11–13 Weeks’ Gestation (2012) (38)
- Repeatability of measurement of uterine artery pulsatility index using transvaginal color Doppler (2001) (38)
- Maternal Serum α-Fetoprotein at 11–13 Weeks’ Gestation in Spontaneous Early Preterm Delivery (2011) (38)
- Dilemmas in the management of twins discordant for anencephaly diagnosed at 11 + 0 to 13 + 6 weeks of gestation (2006) (38)
- Haematopoietic stem cell transplantation and gene therapy in the fetus: ready for clinical use? (2001) (38)
- Hypertriglyceridemia and hypoxemia in small-for-gestational-age fetuses. (1990) (37)
- Additional first-trimester ultrasound markers. (2010) (37)
- Left and right lung volumes in fetuses with diaphragmatic hernia. (2006) (37)
- Amniotic fluid pressure in twin-to-twin transfusion syndrome: an objective prognostic factor. (1996) (37)
- Nuchal translucency thickness and crown‐rump length in twin pregnancies with chromosomally abnormal fetuses. (1995) (37)
- Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length. (2005) (37)
- Fetal fraction of cell‐free DNA in maternal plasma in the prediction of spontaneous preterm delivery (2015) (37)
- Randomized study of vaginal misoprostol (PGE1) and dinoprostone gel (PGE2) for induction of labor at term (2001) (37)
- Maternal abdominal pressure alters fetal cerebral blood flow. (1991) (37)
- Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis. (1995) (37)
- Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first‐trimester screening for chromosomal abnormalities (2017) (37)
- FIRST‐TRIMESTER URINE FREE BETA hCG, BETA CORE, AND TOTAL OESTRIOL IN PREGNANCIES AFFECTED BY DOWN'S SYNDROME: IMPLICATIONS FOR FIRST‐TRIMESTER SCREENING WITH NUCHAL TRANSLUCENCY AND SERUM FREE BETA hCG (1997) (37)
- Routine ultrasound at 32 vs 36 weeks' gestation: prediction of small‐for‐gestational‐age neonates (2019) (36)
- Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy? (2000) (36)
- Prediction of small‐for‐gestational‐age neonates: screening by maternal serum biochemical markers at 19–24 weeks (2015) (36)
- Prenatal detection of rubella‐specific IgM in fetal sera (1985) (36)
- The ultrasonographic assessment of the fetal thorax and fetal breathing movements in the prediction of pulmonary hypoplasia. (1990) (36)
- Integrated Proteomic and Metabolomic prediction of Term Preeclampsia (2017) (36)
- Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization (1989) (36)
- Relationship between second‐trimester uterine artery Doppler and spontaneous early preterm delivery (2006) (36)
- Lamicel: a new technique for cervical dilatation before first trimester abortion (1983) (36)
- Effect of Gestational Age on Fetal and Intervillous Blood Gas and Acid-Base Values in Human Pregnancy (1988) (36)
- First trimester urinary placental growth factor and development of pre‐eclampsia (2009) (36)
- Maternal abdominal pressure alters fetal cerebral blood flow (1990) (36)
- SEVERE FETOMATERNAL ALLOIMMUNE THROMBOCYTOPENIA PRESENTING WITH FETAL HYDROCEPHALUS (1996) (36)
- Computer-assisted analysis of fetal heart rate patterns at 20-41 weeks' gestation. (1990) (36)
- Exhaled nitric oxide concentration and amniotic fluid nitrite concentration during pregnancy (1995) (36)
- Glycosaminoglycans and proteoglycans in the skin of aneuploid fetuses with increased nuchal translucency. (2003) (36)
- Morphometric analysis of the great vessels in early fetal life. (1995) (36)
- First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction (2004) (36)
- Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. (2009) (36)
- Severe perinatal thrombosis in double and triple heterozygous offspring of a family segregating two independent protein S mutations and a protein C mutation. (1996) (35)
- First-trimester maternal serum vitamin D and mode of delivery (2012) (35)
- An integrated model for the prediction of pre-eclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. (2006) (35)
- Assessment of the corpus callosum at 20–24 weeks' gestation by three‐dimensional ultrasound examination (2007) (35)
- Choroid plexus cysts and chromosomal defects. (1990) (35)
- Digital PCR for Noninvasive Detection of Aneuploidy: Power Analysis Equations for Feasibility (2012) (35)
- Effect of parity on maternal cardiac function during the first trimester of pregnancy (2008) (35)
- Maternal Thyroid Function at 11–13 Weeks of Gestation and Spontaneous Preterm Delivery (2011) (35)
- Nuchal Translucency Measurements for First-Trimester Screening: The ‘Price’ of Inaccuracy (2007) (35)
- Fetal middle cerebral artery and umbilical artery pulsatility index: effects of maternal characteristics and medical history (2015) (35)
- Trichorionic triplet pregnancies at 10–14 weeks: outcome after embryo reduction compared to expectant management (2002) (35)
- Maternal serum 25‐hydroxyvitamin D levels at 11+0–13+6 weeks in pregnant women with diabetes mellitus and in those with macrosomic neonates (2011) (35)
- Three‐dimensional evaluation of mid‐facial hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation (2006) (35)
- Outcome of twin pregnancy with two live fetuses at 11–13 weeks' gestation (2019) (35)
- Measurement of fetal nuchal translucency thickness by three‐dimensional ultrasound (2001) (34)
- First trimester maternal serum placenta growth factor (PIGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18 (2001) (34)
- Management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation (2018) (34)
- Intrauterine bone-marrow transplantation at 12 weeks' gestation (1993) (34)
- A case of body stalk anomaly at 10 weeks of gestation (2001) (34)
- Uterine artery pulsatility index at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia (2016) (34)
- Prediction of Preeclampsia by Uterine Artery Doppler at 20-24 Weeks' Gestation (2013) (34)
- Randomized study of early amniocentesis versus chorionic villus sampling: a technical and cytogenetic comparison of 650 patients (1991) (34)
- Personal coping resources, responsibility, anxiety and depression after early pregnancy loss. (1998) (34)
- Longitudinal changes in maternal serum placental growth factor and soluble fms‐like tyrosine kinase‐1 in women at increased risk of pre‐eclampsia (2016) (34)
- Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia (2013) (34)
- Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia (2021) (33)
- Maternal cardiac function during pregnancy at high altitude (2004) (33)
- Competing‐risks model in screening for pre‐eclampsia in twin pregnancy according to maternal factors and biomarkers at 11–13 weeks' gestation (2017) (33)
- Detection of trisomy 21 by quantitative mass spectrometric analysis of single-nucleotide polymorphisms. (2005) (33)
- Screening for pre‐eclampsia at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A, placental growth factor or both (2020) (33)
- Fetal mild hydronephrosis and chromosomal defects: relation to maternal age and gestation. (1995) (33)
- Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction (2018) (33)
- Fetal plasma erythropoietin concentration in red blood cell-isoimmunized pregnancies. (1992) (33)
- Doppler ultrasound assessment of fetal and uteroplacental circulations in severe second trimester oligohydramnios (1987) (33)
- Fetal blood natural killer cells in human pregnancy. (1993) (33)
- Down's syndrome screening in the UK (1996) (33)
- Prediction of stillbirth from biochemical and biophysical markers at 11–13 weeks (2016) (32)
- Mean blood velocities and flow impedance in the fetal descending thoracic aortic and common carotid artery in normal pregnancy. (1988) (32)
- Preterm Prelabor Amniorrhexis: Outcome of Live Births (1995) (32)
- Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies (2014) (32)
- Fetal head‐to‐trunk volume ratio in chromosomally abnormal fetuses at 11 + 0 to 13 + 6 weeks of gestation (2005) (32)
- Maternal serum placental growth factor at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia (2016) (32)
- Contingent screening for preterm pre‐eclampsia (2016) (32)
- Fetal and maternal erythropoietin levels in normal pregnancy. (1992) (32)
- Intrauterine growth in multiple pregnancies in relation to fetal number, chorionicity and gestational age (2008) (32)
- Fetofetal transfusion syndrome in triplet pregnancies: outcome after endoscopic laser surgery. (2005) (32)
- Maternal hemodynamics in normal pregnancy and in pregnancy affected by pre‐eclampsia (2017) (32)
- Maternal serum free β‐hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies (1997) (32)
- Inter‐arm blood pressure differences in pregnant women (2008) (32)
- Development of a training model for ultrasound‐guided invasive procedures in fetal medicine (1995) (32)
- Monozygotic twins discordant for body stalk anomaly (2002) (31)
- Fetal haematology in rhesus isoimmunisation (1985) (31)
- Prediction of small‐for‐gestational‐age neonates: screening by fetal biometry at 19–24 weeks (2015) (31)
- Fetal blood chromosome analysis: some new indications for prenatal karyotyping (1985) (31)
- Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation (2014) (31)
- Clinical Perspective of Cell-Free DNA Testing for Fetal Aneuploidies (2014) (31)
- Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? (2007) (31)
- Studies on fetal physiology and pathophysiology in rhesus disease. (1989) (31)
- Maternal plasma levels of human chorionic gonadotrophin, oestradiol and progesterone in multifetal pregnancies before and after fetal reduction. (1994) (31)
- Sonographic diagnosis of a non‐previa placenta accreta (1996) (31)
- First‐trimester maternal serum tumor necrosis factor receptor‐1 and pre‐eclampsia (2009) (31)
- Two‐stage screening for preterm preeclampsia at 11–13 weeks’ gestation (2019) (31)
- Screening for pre‐eclampsia using sFlt‐1/PlGF ratio cut‐off of 38 at 30–37 weeks' gestation (2017) (30)
- One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation (2002) (30)
- Intrauterine growth retardation and fetal transverse cerebellar diameter (1994) (30)
- Maternal serum level of placental growth factor in diabetic pregnancies. (2004) (30)
- [Fetal nuchal translucency]. (2005) (30)
- Inverted Pyramid of Care. (2016) (30)
- Prevention of Preterm Delivery in Twin Gestations (PREDICT): A Multicenter, Randomized, Placebo-Controlled Trial on the Effect of Vaginal Micronized Progesterone (2012) (30)
- Maternal Serum Vitamin D at 11–13 Weeks in Pregnancies Delivering Small for Gestational Age Neonates (2012) (30)
- Chylothorax after repair of congenital diaphragmatic hernia--risk factors and morbidity. (1998) (29)
- Maternal serum retinol-binding protein-4 at 11-13 weeks' gestation in normal and pathological pregnancies. (2013) (29)
- Diaphragmatic Function in Infants with Surgically Corrected Anomalies (2003) (29)
- Biochemical analyses of mesenchymal fluid in early pregnancy. (1998) (29)
- Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. (1999) (29)
- Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester (2012) (29)
- Prediction of small‐for‐gestational‐age neonates: screening by uterine artery Doppler and mean arterial pressure at 19–24 weeks (2015) (29)
- The fetal concentrating index as a gestational age-independent measure of placental dysfunction in intrauterine growth retardation. (1991) (29)
- Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes. (2020) (29)
- Systematic Identification of Placental Epigenetic Signatures for the Noninvasive Prenatal Detection of Edwards Syndrome (2010) (29)
- Assisted conception and placental perfusion assessed by uterine artery Doppler at 11-13 weeks' gestation. (2011) (29)
- Diagnosis of Fetal Abnormalities by Ultrasound (1986) (29)
- Biomarkers of impaired placentation at 35–37 weeks' gestation in the prediction of adverse perinatal outcome (2019) (29)
- Prediction of small‐for‐gestational‐age neonates at 35–37 weeks' gestation: contribution of maternal factors and growth velocity between 20 and 36 weeks (2019) (29)
- Cervical dilatation by Lamicel—studies on the mechanism of action (1983) (29)
- Tidal breathing parameters in the first week of life and subsequent cough and wheeze. (1996) (29)
- Effects of embryo reduction from trichorionic triplets to twins (1997) (29)
- Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11–13 weeks (2012) (29)
- Systolic, Diastolic and Mean Arterial Pressure at 30-33 Weeks in the Prediction of Preeclampsia (2013) (29)
- Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies (2008) (28)
- Fetal urine production in normal twins and in twins with acute polyhydramnios. (1990) (28)
- Circulating levels of adiponectin and leptin at 23-25 weeks of pregnancy in women with impaired placentation and in those with established fetal growth restriction. (2008) (28)
- Proceedings of the First Annual Meeting of the International Fetoscopic Myelomeningocele Repair Consortium (2019) (28)
- Mean arterial pressure at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia (2016) (28)
- Tracheal side effects following fetal endoscopic tracheal occlusion for severe congenital diaphragmatic hernia (2010) (28)
- The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality? (1998) (28)
- Association of chronic hypertension with birth of small‐for‐gestational‐age neonate (2017) (28)
- Clinical significance of first‐trimester chorionic bumps: a matched case–control study (2013) (28)
- Maternal serum insulin‐like growth factor‐I at 11–13 weeks in preeclampsia (2010) (28)
- Tracheal diameter at birth in severe congenital diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (2011) (28)
- Risks of obstetric complications in multiple pregnancies: an analysis of more than 400 000 pregnancies in the UK (2001) (28)
- Perioperative assessment of respiratory compliance and lung volume in infants with congenital diaphragmatic hernia: prediction of outcome. (1997) (28)
- Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening (2020) (28)
- Prediction of large‐for‐gestational‐age neonate by routine third‐trimester ultrasound (2019) (28)
- Ear length in trisomy 21 fetuses at 11–14 weeks of gestation (2003) (28)
- Strawberry-shaped skull in fetal trisomy 18. (1992) (28)
- Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies. (2012) (28)
- Down's syndrome screening with nuchal translucency (1997) (28)
- Ear length: A potential sonographic marker for Down syndrome (1994) (27)
- Some psychometric properties of the Texas Grief Inventory adjusted for miscarriage. (1999) (27)
- Hepatic artery Doppler in trisomy 21 and euploid fetuses at 11–13 weeks (2011) (27)
- The prevalence and consequences of missed abortion in twin pregnancies at 10 to 14 weeks of gestation (1997) (27)
- Prediction of adverse perinatal outcome by cerebroplacental ratio in women undergoing induction of labor (2019) (27)
- Molecular interactions during pregnancy: Placental expression of α and β subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome (1995) (27)
- Isolated single umbilical artery: need for specialist fetal echocardiography? (2010) (27)
- Fetal programming for adult disease: where next? (2003) (27)
- Competing‐risks model in screening for pre‐eclampsia in twin pregnancy by maternal characteristics and medical history (2017) (27)
- Placental volume in twin and triplet pregnancies measured by three‐dimensional ultrasound at 11 + 0 to 13 + 6 weeks of gestation (2006) (27)
- Routine first‐trimester screening for fetal trisomies in twin pregnancy: cell‐free DNA test contingent on results from combined test (2018) (27)
- Proposed clinical management of pregnancies after combined screening for pre‐eclampsia at 30–34 weeks' gestation (2017) (27)
- Maternal Hemodynamics at 11–13 Weeks of Gestation in Pregnancies Delivering Small for Gestational Age Neonates (2012) (27)
- Metopic suture in fetuses with holoprosencephaly at 11 + 0 to 13 + 6 weeks of gestation (2006) (27)
- Placental lakes, absent umbilical artery diastolic flow and poor fetal growth in early pregnancy (1996) (27)
- Prediction of small‐for‐gestational‐age neonates: screening by uterine artery Doppler and mean arterial pressure at 30–34 weeks (2015) (27)
- Management of twin pregnancies with fetal trisomies (1997) (27)
- Regulation of corpus luteum function. (1994) (27)
- Two‐stage approach for prediction of small‐for‐gestational‐age neonate and adverse perinatal outcome by routine ultrasound examination at 35–37 weeks' gestation (2019) (27)
- First-Trimester Screening for Trisomy 21 Using Alpha-Fetoprotein (2011) (27)
- Proteomic Biomarkers of Preterm Birth Risk in Women with Polycystic Ovary Syndrome (PCOS): A Systematic Review and Biomarker Database Integration (2013) (26)
- Some thoughts on the true value of ultrasound (2007) (26)
- Congenital diaphragmatic hernia—influence of fetoscopic tracheal occlusion on outcomes and predictors of survival (2016) (26)
- Good clinical practice advice: Prediction of preterm labor and preterm premature rupture of membranes (2019) (26)
- Mean red cell volume in normal, anemic, small, trisomic and triploid fetuses. (1989) (26)
- Pleuro-amniotic shunting for fetal chylothorax. (1987) (26)
- Proposed clinical management of pregnancies after combined screening for pre‐eclampsia at 35–37 weeks' gestation (2017) (26)
- SARS-CoV-2 and the subsequent development of preeclampsia and preterm birth: evidence of a dose-response relationship supporting causality (2021) (26)
- Physiological distribution of placental growth factor and soluble Flt‐1 in early pregnancy (2008) (26)
- Temporary impairment of lung function in infants with anterior abdominal wall defects who have undergone surgery. (1996) (26)
- Maternal circulating endothelial progenitor cells in normal singleton and twin pregnancy. (2008) (26)
- Ultrasound findings before amniocentesis in selecting the method of analysing the sample (2007) (26)
- Intertwin discordance in fetal size at 11–13 weeks' gestation and pregnancy outcome (2019) (26)
- Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester (2001) (26)
- Maternal serum PAPP‐A and free β‐hCG at 12, 22 and 32 weeks' gestation in screening for pre‐eclampsia (2016) (25)
- A retrospective multicenter study of the natural history of fetal ovarian cysts. (2018) (25)
- Experience of 300 cases of prenatal fetoscopic open spina bifida repair: Report of the International Fetoscopic Neural Tube Defect Repair Consortium. (2021) (25)
- Maternal Serum Soluble Endoglin at 30-33 Weeks in the Prediction of Preeclampsia (2012) (25)
- Diet and exercise for preeclampsia prevention in overweight and obese pregnant women: systematic review and meta-analysis (2018) (25)
- Frontomaxillary facial angle in fetuses with trisomy 13 at 11 + 0 to 13 + 6 weeks (2007) (25)
- Prediction of small‐for‐gestational‐age neonates: screening by maternal biochemical markers at 30–34 weeks (2015) (25)
- Doppler study of the fetal circulation during long‐term maternal hyperoxygenation for severe early onset intrauterine growth retardation (1991) (25)
- Maternal assessment in the prediction of intrauterine infection in preterm prelabor amniorrhexis. (1995) (25)
- Prenatal diagnosis of mandibulofacial dysostosis (1984) (24)
- The Use of Ultrasound and other Markers for Early Detection of Preeclampsia (2016) (24)
- Nasal‐bone length in euploid fetuses at 16–24 weeks' gestation by three‐dimensional ultrasound (2010) (24)
- CASE REPORT: UNIPARENTAL DISOMY 16 IN ASSOCIATION WITH CONGENITAL HEART DISEASE (1996) (24)
- Prediction of small‐for‐gestational‐age neonates: screening by placental growth factor and soluble fms‐like tyrosine kinase‐1 at 35–37 weeks (2015) (24)
- Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks. (2002) (24)
- Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester (2002) (24)
- Maternal serum alpha‐fetoprotein at 12, 22 and 32 weeks' gestation in screening for pre‐eclampsia (2016) (24)
- Learning curve in measurement of fetal frontomaxillary facial angle at 11–13 weeks of gestation (2010) (24)
- Fetal and embryonic hemoglobins in erythroblasts of chromosomally normal and abnormal fetuses at 10-40 weeks of gestation. (2000) (24)
- Cerebral palsy in triplet pregnancies with and without iatrogenic reduction (2004) (24)
- Maternal Serum Adiponectin at 11–13 Weeks of Gestation in Preeclampsia (2011) (24)
- Posterior brain in fetuses with trisomy 18, trisomy 13 and triploidy at 11 to 13 weeks' gestation (2012) (24)
- Maternal contamination of amniotic fluid demonstrated by DNA analysis (1994) (24)
- Maternal Serum Alpha-Fetoprotein in Normal Pregnancy at 11–13 Weeks’ Gestation (2011) (24)
- Maternal Hemodynamics in Normal Pregnancies at 11–13 Weeks’ Gestation (2012) (24)
- Outcome of pregnancies with trisomy 2 cells in chorionic villi (2010) (24)
- Relation between maternal‐to‐fetal blood glucose gradient and uterine and umbilical Doppler blood flow measurements (1990) (24)
- The effect of replacing fetal hemoglobin with adult hemoglobin on blood gas and acid-base parameters in human fetuses. (1988) (24)
- Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre‐eclampsia at 19–23 weeks' gestation (2020) (24)
- Good clinical practice advice: Antenatal corticosteroids for fetal lung maturation (2019) (24)
- Impact of placenta previa with placenta accreta spectrum disorder on fetal growth (2019) (24)
- Screening for trisomies in dichorionic twins by measurement of fetal nuchal translucency thickness according to the mixture model (2011) (24)
- First‐trimester maternal serum PAPP‐A, SP1 and M‐CSF levels in normal and trisomic twin pregnancies (2003) (24)
- Circulating placental protein 14: in the first trimester of spontaneous and IVF pregnancies. (1993) (24)
- Development of pre‐eclampsia within 4 weeks of sFlt‐1/PlGF ratio > 38: comparison of performance at 31–34 vs 35–37 weeks' gestation (2017) (23)
- Protocol for measurement of mean arterial pressure at 10-40weeks' gestation. (2017) (23)
- Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia. (2001) (23)
- Amniotic fluid pressure during pregnancy. (1990) (23)
- First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status (2000) (23)
- Longitudinal changes in maternal corin and mid‐regional proatrial natriuretic peptide in women at risk of pre‐eclampsia (2015) (23)
- Fetal plasma erythropoietin concentration in severe growth retardation (1993) (23)
- A Case-Control Study of Maternal Periconceptual and Pregnancy Recreational Drug Use and Fetal Malformation Using Hair Analysis (2014) (23)
- Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation (2014) (23)
- Contraction of the levator ani muscle during Valsalva maneuver (coactivation) is associated with a longer active second stage of labor in nulliparous women undergoing induction of labor (2019) (23)
- Congenital segmental emphysema: an evolving lesion. (2010) (23)
- Crown-chin length in normal and anencephalic fetuses at 10 to 14 weeks' gestation. (1997) (23)
- Liver transplantation during pregnancy complicated by cytomegalovirus infection. (1995) (23)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate from maternal characteristics and medical history (2020) (23)
- Maternal serum inhibin‐A and free β‐hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation (1997) (22)
- Coelocentesis: a study of short‐term safety (1997) (22)
- Cervical length at 23 weeks' gestation--relation to demographic characteristics and previous obstetric history in South African women. (2005) (22)
- Early prenatal diagnosis by celocentesis (2004) (22)
- Serum alpha‐fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (22)
- Quantitative recovery of immunoreactive proteins from clinical samples following RNA and DNA isolation. (2003) (22)
- Human erythrocyte superoxide dismutase in adults, neonates, and normal, hypoxaemic, anaemic, and chromosomally abnormal fetuses. (1993) (22)
- Femur and humerus length in trisomy 21 fetuses at 11–14 weeks of gestation (2004) (22)
- Proposed clinical management of pregnancies after combined screening for pre‐eclampsia at 19–24 weeks' gestation (2017) (22)
- Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies. (1996) (22)
- Sonographic markers of aneuploidies at 6-10 weeks of gestation. (2011) (22)
- Superovulation, IGFBP-1 and birth weight. (1995) (22)
- Respiratory function in pregnancy at sea level and at high altitude (2004) (22)
- Heart rate patterns in normoxemic, hypoxemic, and anemic second-trimester fetuses. (1989) (22)
- Calcium homeostasis in second trimester fetuses. (1986) (22)
- Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation (2002) (22)
- Lung volume measured by functional residual capacity in infants following first trimester amniocentesis or chorion villus sampling (1992) (22)
- Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks: effect of plane of acquisition (2007) (22)
- Three‐dimensional ultrasound fetal lung volumes and infant respiratory outcome: a prospective observational study (2011) (22)
- Haemorheological adaptation during pregnancy in a Latin American population (2001) (22)
- Amniotic fluid gram stain and leukocyte count in the prediction of intrauterine infection in preterm prelabour amniorrhexis. (1996) (21)
- Investigation of hypertriglyceridemia in small for gestational age fetuses. (1988) (21)
- Placental and Fetal Doppler (2000) (21)
- Impaired placentation in women with chronic hypertension who develop pre‐eclampsia (2017) (21)
- Prediction of stillbirth from placental growth factor at 11–13 weeks (2016) (21)
- First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free β‐hCG and PAPP‐A (2000) (21)
- Fetal thyroid function. (1992) (21)
- Maternal serum S100 protein in normal and Down syndrome pregnancies (1999) (21)
- Rapid processing of fetal skin for prenatal diagnosis by light and electron microscopy. (1984) (21)
- Impaired vascular reactivity in pregnant women with insulin-dependent diabetes mellitus. (2002) (21)
- Prediction of Recurrent Preeclampsia Using First-Trimester Uterine Artery Doppler (2013) (21)
- Maternal autoimmune disorders and fetal defects (2018) (21)
- Lymphatic capillary hypoplasia in the skin of fetuses with increased nuchal translucency and Turner's syndrome: comparison with trisomies and controls. (2010) (21)
- Morbidity in infants with antenatally-diagnosed anterior abdominal wall defects (2000) (21)
- Uterine artery pulsatility index at 30–34 weeks' gestation in the prediction of adverse perinatal outcome (2016) (21)
- Ultrasound guided invasive procedures in obstetrics. (1983) (21)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate from biophysical and biochemical markers at 11–13 weeks' gestation (2020) (21)
- Blood transferrin receptor expression in chromosomally abnormal fetuses (1995) (21)
- A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth (2016) (21)
- Customized birth weight: coefficients and validation of models in a UK population (2008) (21)
- Permeation of human chorioamniotic membranes by Escherichia coli in vitro. (1994) (21)
- Preeclampsia. (2022) (21)
- Are all infants of diabetic mothers "macrosomic"? (1988) (21)
- First trimester invasive procedures: Effects on symptom status and lung volume in very young children (1997) (21)
- Respiratory function in infancy following pleuro-amniotic shunting. (1993) (21)
- Clinical validation of a novel automated cell‐free DNA screening assay for trisomies 21, 13, and 18 in maternal plasma (2019) (21)
- Deliberately delayed and shortened fetoscopic tracheal occlusion - A different strategy after prenatal diagnosis of life-threatening congenital diaphragmatic hernias (2006) (20)
- Prediction of stillbirth from maternal factors, fetal biometry and uterine artery Doppler at 19–24 weeks (2016) (20)
- Paired maternal and fetal cardiac functional measurements in women with gestational diabetes mellitus at 35-36 weeks' gestation. (2020) (20)
- The role of trophoblast dysfunction in the aetiology of miscarriage (1993) (20)
- Prediction of outcome by computer-assisted analysis of lung area on the chest radiograph of infants with congenital diaphragmatic hernia. (2000) (20)
- Quantitative ELISAs for serum soluble LHCGR and hCG-LHCGR complex: potential diagnostics in first trimester pregnancy screening for stillbirth, Down’s syndrome, preterm delivery and preeclampsia (2012) (20)
- Intra-uterine starvation and fetal leucocyte count. (1991) (20)
- Distress after miscarriage: Relation to the knowledge of the cause of pregnancy loss and coping style (2000) (20)
- Fetal surgery for severe congenital diaphragmatic hernia? (2012) (20)
- Left and right lung volumes in fetuses with diaphragmatic hernia (2006) (20)
- Survival of transfused adult cells in the fetus. (1986) (20)
- Fetal major cardiac defects and placental dysfunction at 11–13 weeks' gestation (2018) (20)
- Lateral ventricles in fetuses with aneuploidies at 11–13 weeks' gestation (2012) (20)
- Flow‐mediated dilatation of the brachial artery in pregnancy at high altitude (2002) (20)
- Maternal Hemodynamics at 11–13 Weeks’ Gestation in Gestational Diabetes Mellitus (2012) (20)
- Hypophosphatasia associated with increased nuchal translucency: a report of two affected pregnancies (2002) (20)
- Good clinical practice advice: Management of twin pregnancy (2019) (20)
- Dilated Fourth Ventricle in Fetuses with Trisomy 18, Trisomy 13 and Triploidy at 11–13 Weeks’ Gestation (2012) (20)
- Protein S and C4b‐binding protein in fetal and neonatal blood (1988) (20)
- Prediction of small for gestational age neonates (2020) (20)
- The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by doppler ultrasound. (1999) (20)
- Maternal serum soluble fms‐like tyrosine kinase‐1 at 12, 22, 32 and 36 weeks' gestation in screening for pre‐eclampsia (2016) (20)
- Maternal cardiac function at 35–37 weeks' gestation: prediction of pre‐eclampsia and gestational hypertension (2017) (20)
- Performance of the neoBona test: a new paired‐end massively parallel shotgun sequencing approach for cell‐free DNA‐based aneuploidy screening (2017) (19)
- First trimester biomarkers for prediction of gestational diabetes mellitus. (2020) (19)
- Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) (2019) (19)
- Dichorionic twins discordant for intrauterine growth retardation (1997) (19)
- Fetal Omphalocele: Associated Malformations and Chmmosomal Defects (1987) (19)
- Early vaginal progesterone versus Placebo in Twin Pregnancies for prevention of spontaneous preterm birth (EVENTS): A randomised double-blind trial. (2020) (19)
- Comparison of screening for pre‐eclampsia at 31–34 weeks' gestation by sFlt‐1/PlGF ratio and a method combining maternal factors with sFlt‐1 and PlGF (2017) (19)
- Ophthalmic artery Doppler in combination with other biomarkers in prediction of pre‐eclampsia at 35–37 weeks' gestation (2020) (19)
- Prenatal diagnosis of the fragile X syndrome using fetal blood and amniotic fluid (1987) (19)
- Maternal plasma glucose at high altitude (2001) (19)
- A link between high serum levels of human chorionic gonadotrophin and chorionic expression of its mature functional receptor (LHCGR) in Down's syndrome pregnancies (2005) (19)
- Thyroid function in fetuses with chromosomal abnormalities. (1991) (19)
- Maternal and pregnancy characteristics affect plasma fibrin monomer complexes and D-dimer reference ranges for venous thromboembolism in pregnancy. (2016) (19)
- Severe hypertension, preeclampsia and small for gestational age in women with chronic hypertension diagnosed before and during pregnancy. (2018) (19)
- Maternal serum soluble adhesion molecule levels at 11+0–13+6 weeks and subsequent development of pre-eclampsia (2007) (19)
- Fetal thyroid-stimulating hormone response to maternal administration of thyrotropin-releasing hormone. (1991) (19)
- Constriction band of the arm following insertion of a pleuro‐amniotic shunt (2000) (19)
- Two‐stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems (2018) (18)
- Gamma-glutamyl transferase activity in fetal serum, maternal serum, and amniotic fluid during gestation. (1984) (18)
- Pregnancy at high altitude: a hyperviscosity state. (2005) (18)
- Maternal thyroid function at eleven to thirteen weeks of gestation and subsequent delivery of small for gestational age neonates. (2011) (18)
- Good clinical practice advice: Iron deficiency anemia in pregnancy (2019) (18)
- Doppler velocimetry and fetal heart rate studies in nephropathic diabetics. (1992) (18)
- Metabolomic analysis for first-trimester trisomy 18 detection. (2013) (18)
- Embryo Reduction in Dichorionic Triplets to Dichorionic Twins by Intrafetal Laser (2013) (18)
- Midbrain and Falx in Fetuses with Absent Corpus Callosum at 11–13 Weeks (2012) (18)
- Cerebral and renal artery blood flow velocity before and after birth. (1996) (18)
- Repeat measurements of uterine artery pulsatility index, mean arterial pressure and serum placental growth factor at 12, 22 and 32 weeks in prediction of pre‐eclampsia (2017) (18)
- Retention of the second twin: a viable option? Case reports (1991) (18)
- Fetal endoscopic tracheal occlusion reverses the natural history of right‐sided congenital diaphragmatic hernia: European multicenter experience (2020) (18)
- Maternal Serum Insulin‐Like Growth Factor Binding Protein‐1 in Pregnancy at High Altitude (2002) (18)
- Platelet size and glycoprotein Ib and IIIa expression in normal fetal and maternal blood. (1994) (18)
- Intelligent Noninvasive Diagnosis of Aneuploidy: Raw Values and Highly Imbalanced Dataset (2017) (18)
- Prenatal diagnosis of fragile X syndrome by placental (chorionic villi) biopsy culture. (1988) (18)
- Treatment of Twin-Twin Transfusion Syndrome by Laser and Digoxin (1998) (18)
- Prognostic indicators in congenital diaphragmatic hernia. (1995) (18)
- The regulation of plasma relaxin levels during human pregnancy. (1994) (18)
- Fetal immunological and haematological changes in intrauterine infection (1994) (18)
- Nasal bone assessment in fetuses with trisomy 21 at 16–24 weeks of gestation by three‐dimensional ultrasound (2012) (18)
- Tracheomegaly in infants with severe congenital diaphragmatic hernia treated with fetal endoluminal tracheal occlusion. (2014) (18)
- Preinduction sonographic measurement of cervical length in prolonged pregnancy: The effect of parity in the prediction of induction-to-delivery interval (2004) (18)
- Distribution of relaxin between human maternal and fetal circulations and amniotic fluid. (1992) (17)
- Effect of a fetal surveillance unit on admission of antenatal patients to hospital. (1991) (17)
- Maternal serum placental growth hormone at 11–13 weeks’ gestation in pregnancies delivering small for gestational age neonates (2012) (17)
- Maternal hemodynamics in screen‐positive and screen‐negative women of the ASPRE trial (2019) (17)
- Prenatal diagnosis and clinical implications of an apparently isolated right aortic arch (2018) (17)
- Total amount of circulating human chorionic gonadotrophin α and β subunits in first trimester trisomies 21 and 18 (1996) (17)
- Congenital diaphragmatic hernia: prognostic indices in the fetal endoluminal tracheal occlusion era. (2009) (17)
- Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11–13 weeks in preeclampsia (2012) (17)
- Pregnancy at high altitude: a hyperviscosity state (2004) (17)
- Prevention of stillbirth: impact of two‐stage screening for vasa previa (2019) (17)
- First‐trimester ultrasound detection of fetal heart anomalies: systematic review and meta‐analysis (2021) (17)
- Fetal haematology in rhesus isoimmunisation. (1985) (17)
- Maternal serum cytokines at 30–33 weeks in the prediction of preeclampsia (2013) (17)
- Distribution of fetal and embryonic hemoglobins in fetal erythroblasts enriched from maternal blood. (2001) (17)
- Expanded conventional first trimester screening (2017) (17)
- Placental function and fetal weight are associated with maternal hemodynamic indices in uncomplicated pregnancies at 35-37 weeks gestation. (2020) (17)
- Diagnosis of fetal defects in twin pregnancies at routine 11–13‐week ultrasound examination (2020) (17)
- Pregnancy loss rates after midtrimester amniocentesis. (2007) (17)
- Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia. (2004) (17)
- Galectin-7 Impairs Placentation and Causes Preeclampsia Features in Mice (2020) (17)
- Increased fetal nuchal translucency: possible association with esophageal atresia (2000) (17)
- The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies. (1997) (17)
- Postnatal respiratory function after chronic drainage of fetal pulmonary cyst. (1988) (17)
- Concentration of fetal plasma and amniotic fluid interleukin-1 in pregnancies complicated by preterm prelabour amniorrhexis. (1995) (17)
- Embryo‐fetal erythroid cell selection from celomic fluid allows earlier prenatal diagnosis of hemoglobinopathies (2016) (17)
- Increased nuchal translucency at 11–13 weeks' gestation and outcome in twin pregnancy (2019) (16)
- Perinatal lung function and invasive antenatal procedures. (1997) (16)
- Uterine artery Doppler at 11–14 weeks of gestation in chromosomally abnormal fetuses (2001) (16)
- Pregnancy: Interactions between the embryo and corpus luteum (1993) (16)
- Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia. (2004) (16)
- Feasibility of DNA diagnosis of haemoglobinopathies on coelocentesis (2011) (16)
- Ophthalmic artery Doppler in prediction of pre‐eclampsia at 35–37 weeks' gestation (2020) (16)
- FIRST-TRIMESTER DIAGNOSIS OF WISKOTT-ALDRICH SYNDROME BY DNA MARKERS (1989) (16)
- Peripheral blood cell microRNA quantification during the first trimester predicts preeclampsia: Proof of concept (2018) (16)
- URINE PRODUCTION AND BLADDER FUNCTION IN FETUSES WITH OPEN SPINA BIFIDA (1988) (16)
- PREDICTING CESAREAN DELIVERY FOR FAILURE TO PROGRESS AS AN OUTCOME OF LABOR INDUCTION IN TERM SINGLETON PREGNANCY. (2021) (16)
- [First trimester diagnosis of chromosomal defects]. (2005) (16)
- Chronic hypertension: effect of blood pressure control on pregnancy outcome (2019) (16)
- Fetal heart rate patterns in red blood cell isoimmunized pregnancies. (1989) (16)
- Changes in maternal plasma macrophage-colony stimulating factor levels during normal pregnancy. (2008) (16)
- 2,3-Diphosphoglycerate in normal, anaemic and transfused human fetuses. (1988) (16)
- Ductus venosus flow at 11–13 weeks in the prediction of birth weight discordance in monochorionic twins (2011) (16)
- Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size (2017) (16)
- Placental and ovarian hormones in anembryonic pregnancy. (1993) (16)
- First trimester prediction of HELLP syndrome (2016) (16)
- The randomized TOTAL-trials on fetal surgery for congenital diaphragmatic hernia: re-analysis using pooled data. (2021) (16)
- First trimester diagnosis of adenosine deaminase deficiency (1987) (16)
- Placental expression of α and β subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome (1995) (16)
- Maternal serum visfatin at 11–13 weeks’ gestation in preeclampsia (2013) (16)
- Sonographic cervical length in threatened preterm labor in a South African population (2004) (15)
- Serum ferritin and cobalamin in growth retarded fetuses (1994) (15)
- Doppler studies of the placental and fetal circulation in pregnancies with preterm prelabor amniorrhexis (1995) (15)
- Maternal cardiac function at 35–37 weeks' gestation: relationship with birth weight (2017) (15)
- Maternal Serum Progesterone-Induced Blocking Factor at 11–13 Weeks’ Gestation in Spontaneous Early Preterm Delivery (2011) (15)
- Maternal serum insulin-like growth factor (IGF-I) and binding proteins IGFBP-1 and IGFBP-3 at 11-13 weeks' gestation in pregnancies delivering small for gestational age neonates. (2012) (15)
- Maternal serum alpha‐fetoprotein in fetal neural tube and abdominal wall defects at 10 to 14 weeks of gestation (1997) (15)
- Temporal Effect of Afro-Caribbean Race on Serum Pregnancy-Associated Plasma Protein-A at 9–13 Weeks’ Gestation in Screening for Aneuploidies (2012) (15)
- Antenatal diagnosis and outcome in hydrops fetalis (1993) (15)
- Pregnancy First-Trimester Prediction of Hypertensive Disorders in Pregnancy (2009) (15)
- Maternal thyroid function at gestational weeks 11-13 in twin pregnancies. (2013) (15)
- Fetal B lymphocyte subpopulations in normal pregnancies. (1992) (15)
- Blackfan–Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation (2002) (15)
- Normal Range of Maternal Serum Vitamin D at 11–13 Weeks’ Gestation (2011) (15)
- Maternal peripheral blood lymphocyte subpopulations in normal and pathological pregnancies. (1994) (15)
- Value of routine ultrasound examination at 35–37 weeks' gestation in diagnosis of non‐cephalic presentation (2020) (15)
- Longitudinal changes in maternal soluble endoglin and angiopoietin‐2 in women at risk for pre‐eclampsia (2014) (15)
- Maternal serum insulin‐like growth factor‐binding protein‐1 (IGFBP‐1) at 11–13 weeks in pre‐eclampsia (2011) (15)
- First trimester maternal serum AFP and total hCG in aneuploidies other than trisomy 21 (2000) (15)
- Impact of biometric measurement error on identification of small‐ and large‐for‐gestational‐age fetuses (2020) (15)
- Fetal immunodeficiency: a consequence of placental insufficiency (1993) (15)
- Second-trimester uterine artery Doppler screening in unselected populations: a review.[see comment] (2002) (15)
- Chronic respiratory morbidity after prolonged and premature rupture of the membranes. (1990) (15)
- Meta-analysis on the Effect of Aspirin Use for Prevention of Preeclampsia on Placental Abruption and Antepartum Hemorrhage (2018) (15)
- Serial lung volume measurements during the perinatal period in infants with abdominal wall defects. (1998) (15)
- Maternal thyroid function in multifetal pregnancies before and after fetal reduction. (2000) (15)
- Cell‐free DNA levels in pregnancies at risk of sickle‐cell disease and significant ethnic variation (2006) (15)
- Down's syndrome screening (1996) (15)
- Early diagnosis of chronic fetal hypoxia in a diabetic pregnancy (1988) (15)
- Amnifiltration in the first trimester: feasibility, technical aspects and cytological outcome (1991) (14)
- Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia (2020) (14)
- Sexing the human fetus and identification of polyploid nuclei by DNA–DNA in situ hybridisation in interphase nuclei (1989) (14)
- Validation of competing‐risks model in screening for pre‐eclampsia in twin pregnancy by maternal factors (2019) (14)
- Pregnancy in Liver Transplantation (2020) (14)
- Evaluation of the fetal assessment score in pregnancies at risk for intrauterine hypoxia. (1993) (14)
- Preterm Prelabour Amniorrhexis (1995) (14)
- Abnormal immunological development in fetuses with trisomy 18 (1994) (14)
- Prediction of small‐for‐gestational‐age neonates at 35–37 weeks' gestation: contribution of maternal factors and growth velocity between 32 and 36 weeks (2019) (14)
- First‐trimester markers of aneuploidy in women positive for HIV (2011) (14)
- Identification of embryo–fetal cells in celomic fluid using morphological and short‐tandem repeats analysis (2016) (14)
- OC01.01: Prevention of preterm delivery in twin gestations (PREDICT): a multicentre randomised placebo‐controlled trial on the effect of vaginal micronised progesterone (2011) (14)
- Prediction of stillbirth from placental growth factor at 19–24 weeks (2016) (14)
- Fetal breathing movements in pregnancies complicated by premature membrane rupture in the second trimester. (1990) (14)
- Pulmonary diffusing capacity in pregnancy at sea level and at high altitude (2003) (14)
- Amniotic fluid and fetal tissues are not heated by obstetric ultrasound scanning (1987) (14)
- Metabolic profiles of adult Wistar rats in relation to prenatal and postnatal nutritional manipulation: The role of birthweight (2014) (14)
- Localization of CAI and CAII isoenzymes in normal term human placenta by immunofluorescence techniques. (1990) (14)
- Search for meaning, finding meaning and adjustment in women following miscarriage: A longitudinal study (2014) (14)
- Maternal electrolyte and liver function changes during pregnancy at high altitude. (2003) (14)
- A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre‐eclampsia (2021) (14)
- Maternal cardiovascular function at 35–37 weeks' gestation: relation to maternal characteristics (2017) (14)
- Endothelial nitric oxide synthase gene polymorphism ( Glu 298 Asp ) and development of pre-eclampsia : a case-control study and a meta-analysis (2005) (14)
- OC08.05: Impact of 1st trimester aspirin on population prevalence of pre‐eclampsia (2009) (14)
- URINARY β‐CORE hCG: SCREENING FOR ANEUPLOIDIES IN EARLY PREGNANCY (11–14 WEEKS' GESTATION) (1997) (14)
- Preterm prelabour amniorrhexis: relation to histological chorioamnionitis. (1996) (14)
- Effect of temperature on free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein‐A concentration (2010) (14)
- Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age (2017) (14)
- On the feasibility of inducing tolerance in man: a study in the cynomolgus monkey. (1989) (14)
- Measurement of Cu/Zn SOD in placenta, cultured cells, various fetal tissues, decidua and semen by ELISA. (1998) (13)
- Fetal haematological response to intra-uterine infection in preterm prelabour amniorrhexis. (1995) (13)
- Down syndrome screening marker levels in women with a previous aneuploidy pregnancy (2005) (13)
- Preoperative dilatation of the first-trimester cervix: a comparison between Lamicel and 16,16-dimethyl-trans delta 2 prostaglandin E1 methyl ester pessaries. (1984) (13)
- Maternal Plasma P-selectin at 11 to 13 Weeks of Gestation in Hypertensive Disorders of Pregnancy (2011) (13)
- PRENATAL EXCLUSION OF HEREDITARY RETINOBLASTOMA (1988) (13)
- Genome‐wide cfDNA testing of maternal blood (2020) (13)
- Prevalence of fetal facial cleft at different stages of pregnancy (1995) (13)
- Prenatal diagnosis of alpha‐1‐antitrypsin deficiency by fetal blood sampling (1987) (13)
- Maternal serum levels of total activin‐A in first‐trimester trisomy 21 pregnancies (2001) (13)
- Mass Spectral Analysis of Asymmetric Hemoglobin Hybrids: Demonstration of Hb FS (α2γβS) in Sickle Cell Disease (2001) (13)
- INTERPRETATION OF FETAL BREATHING MOVEMENTS IN OLIGOHYDRAMNIOS DUE TO MEMBRANE RUPTURE (1988) (13)
- Natural Killer Cells and Their Activation Status in Normal Pregnancy (2013) (13)
- Umbilical cord hematoma associated with an umbilical cord cyst and fetal death at 28 weeks of gestation. (2000) (13)
- Cardiac function in gestational diabetes mellitus: A longitudinal study from fetal life to infancy (2020) (13)
- Why cell culture is successful after early amniocentesis. (1991) (13)
- Fetal choroid plexus cysts (1995) (13)
- Can Staining of Damaged Proteins in Urine Effectively Predict Preeclampsia? (2016) (13)
- Metformin use in Obese mothers is Associated with Improved Cardiovascular Profile in the Offspring. (2020) (13)
- Hematologic profile of neonates with growth restriction is associated with rate and degree of prenatal Doppler deterioration (2013) (13)
- Corpus luteum failure in ectopic pregnancy. (1993) (13)
- Good clinical practice advice: First trimester screening and prevention of pre‐eclampsia in singleton pregnancy (2019) (13)
- Assessment of body composition in Wistar rat offspring by DXA in relation to prenatal and postnatal nutritional manipulation (2016) (12)
- Prediction of outcome in dichorionic twin pregnancies at 6-10 weeks' gestation. (2011) (12)
- Triplets: outcomes of expectant management versus multifetal reduction for 127 pregnancies. (2001) (12)
- Mosaic trisomy 7 confined to the placenta. (1988) (12)
- Maternal Serum Human Placental Growth Hormone (hPGH) at 11 to 13 Weeks of Gestation in Preeclampsia (2011) (12)
- Does website‐based information add any value in counseling mothers expecting a baby with severe congenital diaphragmatic hernia? (2013) (12)
- Advanced maternal age and smoking: risk factors for admission to a neonatal intensive care unit (1996) (12)
- Maternal arterial stiffness in pregnancies affected by Type 1 diabetes mellitus (2009) (12)
- Reference Ranges for the Size of the Fetal Cardiac Outflow Tracts From 13 to 36 Weeks Gestation: A Single-Center Study of Over 7000 Cases (2018) (12)
- Fetal C-reactive protein. (1993) (12)
- FETAL PLATELET TRASFUSIONS IN THE MANAGEMENT OF ALLOIMMUNE THROMBOCYTOPENIA (1987) (12)
- Renal artery blood flow velocity in very low birthweight infants with intrauterine growth retardation. (1993) (12)
- First-trimester screening for Down's syndrome. (2004) (12)
- Association between maternal haemoglobin at 27-29weeks gestation and intrauterine growth restriction. (2015) (12)
- Endocrinology of in-vitro fertilization pregnancies during the first trimester. (1993) (12)
- PRENATAL DIAGNOSIS OF RUBELLA (1984) (12)
- Relations between the fetal circulation and pituitary‐thyroid function (1991) (12)
- PRENATAL DIAGNOSIS OF A RED-CELL ENZYMOPATHY: TRIOSE PHOSPHATE ISOMERASE DEFICIENCY (1989) (12)
- Vaginal progesterone for the prevention of preterm birth and adverse perinatal outcomes in twin gestations with a short cervix: an updated individual patient data meta‐analysis (2021) (12)
- Antenatal and postnatal treatment of pleural effusion and extra-lobar pulmonary sequestration (1996) (12)
- Second-Trimester Screening for Trisomy-21 Using Prefrontal Space Ratio (2013) (12)
- Assessment of endothelial function in normal twin pregnancy (2001) (12)
- Uterine artery Doppler and mid-trimester maternal plasma homocysteine in subsequent pre-eclampsia (2004) (12)
- First‐trimester uterine artery Doppler examination in pregnancies complicated by gestational diabetes mellitus with or without pre‐eclampsia (2013) (12)
- Evaluation of Abdominal Fetal Electrocardiography in Early Intrauterine Growth Restriction (2017) (12)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate from estimated fetal weight at 19–24 weeks' gestation (2021) (12)
- Prenatal diagnosis of triosephosphate isomerase deficiency. (1996) (12)
- Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. (2017) (12)
- ADAM12‐s in coelomic fluid and maternal serum in early pregnancy (2006) (12)
- Maternal Thyroid Function at 11–13 Weeks of Gestation in Women with Hypothyroidism Treated by Thyroxine (2010) (12)
- First-Trimester Screening for Trisomy 21 by Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A : Impact of Maternal and Pregnancy Characteristics (2008) (11)
- Neuromuscular Blockade and Lung Function during Resuscitation of Infants with Congenital Diaphragmatic Hernia (2012) (11)
- Maternal serum Schwangerschafts protein-1 (SP1) and fetal chromosomal abnormalities at 10-13 weeks' gestation. (1995) (11)
- Stratification of pregnancy care based on risk of pre‐eclampsia derived from uterine artery Doppler at 19–24 weeks' gestation (2021) (11)
- Effect on low implantation of the placenta on maternal blood pressure and placental function (1982) (11)
- Accuracy of First-Trimester Combined Test in Screening for Trisomies 21, 18 and 13 (2017) (11)
- Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan : Association with chromosomal defects and reproducibility of the method (2006) (11)
- Chlamydia trachomatis infection in prelabour amniorrhexis (1997) (11)
- Screening for pre-eclampsia at 11-13 weeks' gestation: use of PAPP-A, PlGF or both. (2020) (11)
- Maternal and Fetal Thyroid Function in Pregnancy (1995) (11)
- Metopic suture in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation (2006) (11)
- Temporary iatrogenic fetal tricuspid valve atresia in a case of twin to twin transfusion syndrome. (1994) (11)
- FETAL URINE PRODUCTION IN NORMAL TWINS AND IN TWINS WITH ACUTE POLYHYDRAMNIOS (1990) (11)
- Maternal Serum Placental Growth Factor Isoforms 1 and 2 at 11-13, 20-24 and 30-34 Weeks' Gestation in Late-Onset Pre-Eclampsia and Small for Gestational Age Neonates (2014) (11)
- Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency. (1997) (11)
- Erythroblastosis in birth asphyxia (1992) (11)
- First trimester maternal serum alpha‐fetoprotein in fetal trisomies (1995) (11)
- Serum free β‐human chorionic gonadotropin in the three trimesters of pregnancy: effects of maternal characteristics and medical history (2015) (11)
- Hormonal levels in the human fetus between 14 and 22 weeks gestation. (1987) (11)
- Targeted cell‐free DNA analysis with microarray quantitation for assessment of fetal sex and sex chromosome aneuploidy risk (2018) (11)
- Ventilatory requirements for respiratory distress syndrome in small-for-gestational-age infants (2005) (11)
- Invasive antenatal procedures and requirement for neonatal intensive care unit admission (1997) (11)
- Intrafetal laser ablation for embryo reduction from dichorionic triplets to dichorionic twins (2017) (11)
- Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in fetal anemia. (2001) (11)
- Prediction of pre‐eclampsia in twin pregnancy by maternal factors and biomarkers at 11–13 weeks' gestation: data from EVENTS trial (2020) (11)
- Maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in multifetal pregnancies before and after fetal reduction. (1995) (11)
- Methodology of Doppler assessment of the placental and fetal circulations (2000) (11)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate from maternal characteristics and serum pregnancy‐associated plasma protein‐A at 11–13 weeks' gestation (2020) (11)
- VP48.07: The effect of parity on longitudinal maternal hemodynamics (2019) (11)
- Re‐evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case–control and cohort study (2021) (11)
- Comparison of protocols for extracting circulating DNA and RNA from maternal plasma. (2005) (11)
- Severe hemolytic disease of the fetus following in vitro fertilization with anonymously donated oocytes (2003) (11)
- Maternal serum anti-Müllerian hormone at 11–13 weeks’ gestation in the prediction of preeclampsia (2015) (11)
- First-trimester contingent screening for trisomies 21, 18 and 13 by fetal nuchal translucency and ductus venosus flow and maternal blood cell-free DNA testing (2015) (10)
- Fetal plasma interferon gamma concentration in normal pregnancy. (1993) (10)
- Diagnosis and treatment of feto-maternal hemorrhage in a fetus with homozygous von Willebrand's disease. (1988) (10)
- Molecular interactions during pregnancy Placental mRNA expression of α and β human chorionic gonadotrophin in early trisomy 18 pregnancies (1996) (10)
- Chronic hypertension and superimposed preeclampsia: screening and diagnosis. (2021) (10)
- Second‐trimester levels of pregnancy‐associated plasma protein‐A and free β‐hCG in pregnancies with trisomy 13 (2005) (10)
- Maternal Cardiac Function and Uterine Artery Doppler at 11???14 Weeks in the Prediction of Preeclampsia in Nulliparous Women (2008) (10)
- Cervix on Ultrasound in Singleton Gestations without Prior Spontaneous Preterm Birth : a Systematic Review and Meta-analysis of Trials using individual patient-level data (2017) (10)
- Nonparametric Density Estimation and Discrimination from Images of Shapes (1997) (10)
- Protocol for the prospective validation study: ‘Screening programme for pre‐eclampsia’ (SPREE) (2017) (10)
- Umbilical cord diameter at 11–14 weeks of gestation: relation to chromosomal defects (2004) (10)
- Neutrophil and monocyte β2-integrin expression in maternal and fetal blood (1995) (10)
- Fully Automated 3-D Ultrasound Segmentation of the Placenta, Amniotic Fluid, and Fetus for Early Pregnancy Assessment (2021) (10)
- Lung function at follow‐up of infants with surgically correctable anomalies (2012) (10)
- Prenatal diagnosis of orbital heterotopic brain tissue. (1997) (10)
- Fetal blood sampling. (1988) (10)
- Predicting the severity of fetal anemia using time‐domain measurement of volume flow in the fetal aorta (2004) (10)
- Antenatal testing to predict outcome in pregnancies with unexplained antepartum haemorrhage (1992) (10)
- Short communication: trophoblast proliferation is increased in chorionic villi from pregnancies with fetal trisomy 18. (2000) (10)
- Maternal serum angiopoietin‐2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy (2009) (10)
- Fetal polycythemia and thrombocytopenia in pregnancies complicated by maternal diabetes mellitus (1992) (10)
- Maternal Age and Adverse Pregnancy Outcomes: A Cohort Study (2013) (10)
- Nuchal translucency and gestational age. (2004) (10)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate from maternal characteristics, serum pregnancy‐associated plasma protein‐A and placental growth factor at 11–13 weeks' gestation (2020) (10)
- Competing risks model for prediction of small for gestational age neonates from biophysical markers at 19-24 weeks' gestation. (2021) (10)
- Maternal serum activin-A at 30–33 weeks in the prediction of preeclampsia (2013) (10)
- C-reactive protein at 11–13 weeks’ gestation in spontaneous early preterm delivery (2012) (10)
- Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation. (1996) (10)
- Prenatal incidence of isolated right aortic arch and double aortic arch (2019) (10)
- Fetal leucocyte count in rhesus disease. (1992) (10)
- Interactions between the embryo and corpus luteum. (1993) (9)
- Multiplex ligation-dependent probe amplification (MLPA): a reliable alternative for fetal chromosome analysis? (2012) (9)
- [Sonographic features of chromosomal defects at 11(+0) to 13(+6) weeks of gestation]. (2005) (9)
- Comparison of different methods of measuring angle of progression in prediction of labor outcome (2020) (9)
- Management of severe twin to twin transfusion syndrome (1996) (9)
- Screening for trisomy at 11–13 weeks' gestation: use of pregnancy‐associated plasma protein‐A, placental growth factor or both (2020) (9)
- Chorionic Villus Sampling at 11 to 13 Weeks of Gestation and Hypertensive Disorders in Pregnancy (2010) (9)
- Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. (1995) (9)
- Design of a flexible fetoscopy manipulation system for congenital diaphragmatic hernia. (2014) (9)
- Maternal Serum Placental Protein 13 at Eleven to Thirteen Weeks in Chromosomally Abnormal Pregnancies (2010) (9)
- Heart rate patterns in fetal anemia. (1988) (9)
- IONA test for first‐trimester detection of trisomies 21, 18 and 13 (2015) (9)
- Maternal thyroid function at 11–13 weeks of gestation in fetal trisomies 21 and 18 (2011) (9)
- Pre-term pre-labour amniorrhexis. (1996) (9)
- Impaired placental perfusion and major fetal cardiac defects (2018) (9)
- Prenatal diagnosis of fetal anomalies (2009) (9)
- Steroid sulphatase activity in trophoblast samples (1984) (9)
- Serum prolactin concentration in normal and small for gestational age fetuses (1992) (9)
- Fetal blood ferritin and cobalamin in normal pregnancy. (1994) (9)
- Percutaneous fetoscopic spina bifida repair: effect on ambulation and need for postnatal cerebrospinal fluid diversion and bladder catheterization (2021) (9)
- Fetal blood mononuclear cell division in normal and pathological pregnancies. (1994) (9)
- The inheritance of a Macaca fascicularis red cell antigen detected by CAMPATH-1 antibody. (1987) (9)
- Regulatory T Cells in Pregnancy Adverse Outcomes: A Systematic Review and Meta-Analysis (2021) (9)
- Twin pregnancy with two live fetuses at 11–13 weeks: effect of one fetal death on pregnancy outcome (2019) (9)
- Maternal serum soluble fms‐like tyrosine kinase‐1 at 22 and 32 weeks in the prediction of pre‐eclampsia (2016) (9)
- Down's syndrome screening in the UK. (1996) (9)
- Brachycephaly and frontal lobe hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks (2006) (9)
- Measurement of carbonic anhydrase isoenzymes in early human placental tissues. (1990) (9)
- Celocentesis for early prenatal diagnosis of hemoglobinopathy (2020) (9)
- Feto-maternal bleeding following coelocentesis. (1997) (9)
- Effect of change in posture on maternal functional hemodynamics at 35–37 weeks' gestation (2018) (9)
- Maternal hemodynamics at 11–13 weeks of gestation and preterm birth (2012) (9)
- Inter-arm Blood Pressure Differences in Pregnant Women (2009) (8)
- There is insufficient evidence to claim that cerclage is the treatment of choice for patients with a cervical length <10 mm. (2018) (8)
- Screening for placental insufficiency by uterine artery doppler (2001) (8)
- First‐trimester invasive procedures and congenital abnormalities * (1997) (8)
- 6 Diagnosis and management of fetal malformations (1987) (8)
- The lambda sign in twin pregnancies (1996) (8)
- Aneuploidy screening in coelomic samples using fluorescence in situ hybridisation (FISH) (2005) (8)
- PRENATAL DIAGNOSIS OF JUNCTIONAL EPIDERMOLYSIS BULLOSA (1989) (8)
- Revised competing‐risks model in screening for pre‐eclampsia in twin pregnancy by maternal characteristics and medical history (2019) (8)
- Fetal aneuploidy diagnosed at celocentesis for early prenatal diagnosis of congenital hemoglobinopathies (2018) (8)
- Aldosterone Concentration in Normal, Growth‐Retarded, Anemic, and Hydropic Fetuses (1994) (8)
- Endoscopic Placental Laser Coagulation in Dichorionic and Monochorionic Triplet Pregnancies (2016) (8)
- Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin (2017) (8)
- Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10–14 weeks (2001) (8)
- Carbonic anhydrase isoenzymes CAI and CAII in semen, decidua, chorionic villi and various fetal tissues. (1998) (8)
- Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11–13 Weeks? (2011) (8)
- 558: Short term neonatal morbidity in severe left-sided congenital diaphragmatic hernia treated by tracheal occlusion before 30 weeks (2007) (8)
- Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report (1991) (8)
- Fetal tissue biopsy: techniques and indications. (1986) (8)
- Maternal hemoglobin at 27–29 weeks’ gestation and severity of pre-eclampsia (2015) (8)
- Relaxin concentrations in exoembryonic fluids during the first trimester. (1994) (8)
- Distribution of fetal erythroblasts in maternal blood after chorionic villous sampling (2003) (8)
- Fetal and maternal hCG concentration in aneuploid pregnancies (1995) (8)
- Cordocentesis in the assessment of the small-for-gestational age fetus. (1988) (8)
- Normal levels of ATP, total nucleotides and activities of three enzymes related to nucleotide metabolism in fetal erythrocytes (1986) (8)
- Liver volume in trisomy 21 and euploid fetuses at 11 to 13 weeks (2011) (8)
- Lung function following first-trimester amniocentesis or chorion villus sampling. (1991) (8)
- [Fetal nuchal translucency thickness and risk for chromosomal defects]. (2005) (8)
- Maternal Plasma Plasminogen Activator Inhibitor-2 at 11 to 13 Weeks of Gestation in Hypertensive Disorders of Pregnancy (2011) (8)
- Prevention program of type I Glanzmann thrombasthenia in Israel: prenatal diagnosis. (1988) (8)
- Assessment of efficacy of cell separation techniques used in the enrichment of foetal erythroblasts from maternal blood: triple density gradient vs. single density gradient. (2004) (8)
- Fetal loss after chorionic villus sampling in twin pregnancy (2021) (8)
- 2 Screening for fetal abnormalities in multiple pregnancies (1998) (8)
- STATIN trial: predictive performance of competing‐risks model in screening for pre‐eclampsia at 35–37 weeks' gestation (2021) (8)
- A cc ep te d A rti cl e Repeat measurements of uterine artery pulsatility index , mean arterial pressure and serum placental growth factor at 12 , 22 and 32 weeks in the prediction of preeclampsia (2017) (8)
- The feto-placental unit stimulates the pregnancy-associated increase in maternal bone metabolism. (2000) (8)
- Fetal right ventricular contraction and relaxation times at 11–13 weeks' gestation on speckle tracking imaging (2014) (7)
- Fetal intra‐abdominal bowel dilation in prediction of complex gastroschisis (2019) (7)
- Prenatal diagnosis of genetic skin disease by fetoscopy and electron microscopy: report on 5 years' experience (1985) (7)
- Establishing a Differential Marker Profile for Pregnancy Complications Near Delivery. (2019) (7)
- Coelomic Fluid Leptin Concentration in Normal First-Trimester Pregnancies and Missed Miscarriages (2005) (7)
- Cell‐free DNA testing of maternal blood in screening for trisomies in twin pregnancy: updated cohort study at 10–14 weeks and meta‐analysis (2021) (7)
- Prenatal diagnosis. Fetoscopy. (1984) (7)
- 2253: Prenatal prediction of survival in isolated left-sided diaphragmatic hernia (2006) (7)
- Maternal serum human placental growth hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies (2010) (7)
- Maternal Cardiac Function at Midgestation and Development of Preeclampsia (2022) (7)
- Fetal bone metabolism in normal and rhesus isoimmunised pregnancies (2001) (7)
- Lung-to-Head Ratio and liver position to predict outcome in early diagnosed isolated left sided diaphragmatic hernia fetuses: A multicenter study (2004) (7)
- Evaluation of the RCOG guideline for the prediction of neonates that are small for gestational age and comparison with the competing risks model (2021) (7)
- Diagnosis of fetal defects in twin pregnancies at routine ultrasound examination at 11-13 weeks' gestation. (2019) (7)
- 7 Fetal blood sampling (1987) (7)
- Impact of gestational diabetes mellitus on fetal cardiac morphology and function: cohort comparison of second‐ and third‐trimester fetuses (2020) (7)
- Maternal cardiac function in women at high risk for pre‐eclampsia treated with 150 mg aspirin or placebo: an observational study (2020) (7)
- Fetal erythroblasts in maternal blood in relation to gestational age (2003) (7)
- Invasive techniques for prenatal diagnosis and therapy. (1987) (7)
- Can aneroid sphygmomanometers be used at altitude? (2006) (7)
- Fetal hydrometrocolpos (1993) (7)
- Perinatal medicine G 30 TRANSIENT ADRENOCORTICAL INSUFFICIENCY OF PREMATURITY ( TAP ) AND SYSTEMIC HYPOTENSION IN VERY LOW BIRTH WEIGHT INFANTS (2003) (7)
- Overexpression of esterase D in kidney from trisomy 13 fetuses. (1993) (7)
- Maternal cardiac function at 19–23 weeks' gestation in prediction of pre‐eclampsia (2020) (7)
- Clinical validation of bioreactance for the measurement of cardiac output in pregnancy (2020) (7)
- Second‐ and third‐trimester serum levels of growth‐differentiation factor‐15 in prediction of pre‐eclampsia (2020) (7)
- Permeation of human chorioamniotic membranes by Escherichia coli in vitro (1994) (7)
- Myeloperoxidase activity and nuclear segmentation of maternal neutrophils during normal pregnancy. (2008) (7)
- 693: Natural history of stillbirth in placenta based fetal growth restriction - Implications for surveillance (2008) (7)
- Second‐trimester contingent screening for small‐for‐gestational‐age neonate (2021) (7)
- Fetal heart rate following coelocentesis. (1997) (7)
- Risk of fetal loss after chorionic villus sampling in twin pregnancy derived from propensity score matching analysis (2021) (7)
- First trimester umbilical venous Doppler sonography in chromosomally normal and abnormal fetuses. (1999) (7)
- Effect of Chorionic Villus Sampling on Uterine Artery Doppler (2010) (7)
- Fetal breathing movements in pregnancies complicated by premature membrane rupture in the second trimester (1990) (7)
- Transferrin receptor expression in fetal blood mononuclear cells (1993) (7)
- 56: Neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia (CDH) in the FETO era (2011) (7)
- Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus (1993) (7)
- Evaluation of cardiac performance by abdominal fetal ECG in twin‐to‐twin transfusion syndrome (2012) (7)
- Fetal and embryonic hemoglobins in erythroblasts from fetal blood and fetal cells enriched from maternal blood in pregnancies complicated by maternal diabetes mellitus (2004) (7)
- The mitral gap at 11 + 0 to 13 + 6 weeks: marker of trisomy 21 or artifact? (2007) (6)
- Maternal cardiac function at 19–23 weeks' gestation in prediction of gestational diabetes mellitus (2021) (6)
- Fragile X syndrome. (1987) (6)
- Maternal race and pre‐eclampsia: Cohort study and systematic review with meta‐analysis (2022) (6)
- ASPRE Trial: Incidence of Preterm Preeclampsia in Patients Fulfilling ACOG and NICE Criteria According to Risk by FMF Algorithm (2018) (6)
- Small fetal transverse cerebellar diameter: a screening test for spina bifida (1994) (6)
- Treatment of fetal growth retardation (1989) (6)
- First-Trimester Screening for Trisomy 21 with Adjustment for Biochemical Results of Previous Pregnancies (2011) (6)
- Good clinical practice advice: Micronutrients in the periconceptional period and pregnancy (2019) (6)
- First‐trimester screening for trisomies in pregnancies with vanishing twin (2019) (6)
- Rapid determination of fetal sex in coelomic and amniotic fluid by fluorescence in situ hybridisation. (1995) (6)
- Cell‐free fetal DNA in celomic fluid (2008) (6)
- Prenatal diagnosis and therapy (2006) (6)
- Vaginal Progesterone for Preventing Preterm Birth and Adverse Perinatal Outcomes in Singleton Gestations With a Short Cervix: A Meta-Analysis of Patient Data (2018) (6)
- Association of thyroid peroxidase antibodies and thyroglobulin antibodies with thyroid function in pregnancy - an individual participant data meta-analysis. (2022) (6)
- Development and validation of model for prediction of placental dysfunction‐related stillbirth from maternal factors, fetal weight and uterine artery Doppler at mid‐gestation (2021) (6)
- Features of chromosomal defects (1999) (6)
- In utero resuscitation after cardiac arrest in a fetus. (1984) (6)
- Prenatal cerebellar growth is altered in congenital diaphragmatic hernia on ultrasound (2021) (6)
- Mini-combined test compared with NICE guidelines for early risk-assessment for pre-eclampsia: the SPREE diagnostic accuracy study (2020) (6)
- OC07.02: Multicentre screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation comparison to NICE guidelines and ACOG recommendations (2017) (6)
- THE PRENATAL MANAGEMENT OF NEURAL TUBE DEFECTS: TIME FOR A RE-APPRAISAL (2012) (6)
- Red cell glycolytic intermediates in normal, anaemic and transfused human fetuses (1989) (6)
- Lung-to-head ratio and liver position to predict neonatal morbidity in fetuses with isolated congenital diaphragmatic hernia: A multicenter study (2006) (6)
- Obstetric management and diagnosis of haematological disease in the fetus. (1985) (6)
- Respiratory muscle strength in healthy infants and those with surgically correctable anomalies (2015) (6)
- Reference ranges for fetal heart rate patterns in normoxaemic nonanaemic fetuses. (1989) (6)
- Effective Aspirin Treatment of Women at Risk for Preeclampsia Delays the Metabolic Clock of Gestation (2021) (6)
- Crown–rump length measurement error: impact on assessment of growth (2021) (6)
- Two- and three-dimensional imaging of coarctation shelf in the human fetus (2008) (5)
- First-trimester transabdominal fetoscopy (1992) (5)
- The role of cordocentesis in the diagnosis of fetal well-being. (1994) (5)
- Thyroid function and disease in the fetus and neonate (1992) (5)
- First-Trimester Markers of Aneuploidy and the Prediction of Small-for-Gestational Age Fetuses (2008) (5)
- Second-trimester sex hormone-binding globulin and subsequent development of pre-eclampsia (2004) (5)
- Maternal serum screening marker levels in women with a previous aneuploidy pregnancy (2009) (5)
- Comparison of umbilical artery flow velocity waveform indices as measured by continuous wave Doppler ultrasound. (1988) (5)
- Standard views for examination of the fetus (1999) (5)
- Maternal cardiac adaptation and fetal growth. (2020) (5)
- Aneuploidy screening in a coelomic sample from a missed abortion using sequential fluorescence in situ hybridization. (2006) (5)
- Color Doppler imaging of the uterine artery in pregnancy (1992) (5)
- Maternal plasma cell-free DNA in the prediction of pre-eclampsia (2015) (5)
- Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis (2020) (5)
- Relationship between ophthalmic artery Doppler and maternal cardiovascular function (2021) (5)
- EVOLUTION OF SONOGRAPHIC FINDINGS IN A FETUS WITH AGENESIS OF THE URETHRA, VAGINA, AND RECTUM (1996) (5)
- Chronic hypertension in pregnancy stratified by first‐trimester blood pressure control and adverse perinatal outcomes: A prospective observational study (2021) (5)
- Nuchal translucency (NT) measurements for 1st trimester screening: The “price” of inaccuracy (2004) (5)
- Peri-operative management of percutaneous fetoscopic spina-bifida repair: a descriptive review of five cases from the United Kingdom, with focus on anaesthetic implications. (2020) (5)
- First-trimester metabolomic prediction of stillbirth (2019) (5)
- Screening at 11-13+6 weeks' gestation. (2012) (5)
- Hematoma of the umbilical cord secondary to cordocentesis for intrauterine fetal transfusion (1990) (5)
- 62: Integration of venous doppler and biophysical profile provides optimal delivery timing in fetal growth restriction (FGR) (2007) (5)
- Stratification of pregnancy care based on risk of pre‐eclampsia derived from biophysical and biochemical markers at 19–24 weeks' gestation (2021) (5)
- Fetal lymphocyte subpopulations in red blood cell iso‐immunised pregnancies (1994) (5)
- Serum PlGF compared with PAPP‐A in first trimester screening for preterm pre‐eclampsia: Adjusting for the effect of aspirin treatment (2022) (5)
- 2252: Relation between lung-to-head ratio and lung volume in normal fetuses and fetuses with diaphragmatic hernia (2006) (5)
- Cardiac gene expression of GATA‐4 transcription factor in human trisomy 21 fetuses with increased nuchal translucency (1998) (5)
- Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high risk of preterm pre‐eclampsia (2019) (5)
- Maternal Serum Adiponectin at 11–13 Weeks of Gestation in Pregnancies Delivering Small for Gestation Neonates (2011) (5)
- Management of red cell isoimmunised pregnancies (1998) (5)
- First Trimester Ultrasound Screening: An Update (2010) (5)
- Early vaginal bleeding has no impact on markers used in first trimester aneuploidy screening (2010) (5)
- Maternal serum concentrations of pregnancy associated placental protein A and pregnancy specific beta-1-glycoprotein in multifetal pregnancies before and after fetal reduction. (1996) (5)
- The localisation of copper/zinc superoxide dismutase in human normal term placenta by an immunofluorescence technique. (1998) (4)
- Impact of prenatal and postnatal nutritional manipulation on bone quality in adult Wistar rats offspring (2021) (4)
- Maternal serum ferritin at 11- to 13-week gestation in spontaneous early preterm delivery (2012) (4)
- First trimester maternal uterine artery Doppler examination in HIV‐positive women (2011) (4)
- Screening for fetal abnormalities in multiple pregnancies. (1998) (4)
- Comment on the paper ‘Spina bifida in a 13‐week fetus with a normal intracranial translucency’ published in Prenatal Diagnosis by Arigita et al. 2011 (2012) (4)
- Rapid detection of chromosome aneuploidies in fetal blood and chorionic villi by fluorescence in situ hybridisation (1994) (4)
- Perinatal lung function measurements and prediction of respiratory problems in infancy (1998) (4)
- Re: Implementation of routine first trimester combined screening for pre‐eclampsia: a clinical effectiveness study (2020) (4)
- Ophthalmic artery Doppler in the prediction of preeclampsia. (2021) (4)
- TRANSABDOMINAL PLACENTAL BIOPSY (1987) (4)
- Maternal cardiac function in gestational diabetes mellitus at 35–36 weeks' gestation and 6 months postpartum (2020) (4)
- Neutrophil and monocyte beta 2-integrin expression in maternal and fetal blood. (1995) (4)
- Evolution in screening for Down syndrome (2019) (4)
- Predictive performance for placental dysfunction related stillbirth of the competing risks model for small‐for‐gestational‐age fetuses (2021) (4)
- Prediction of small-for-gestational-age neonates : maternal biochemical markers at 30 – 34 weeks (2015) (4)
- Performance characteristics of Elecsys free βhCG and PAPP-A for first trimester trisomy 21 risk assessment in gestational weeks 8+0 to 14+0 (2016) (4)
- Fetal plasma tumor necrosis factor concentration in normal pregnancy. (1993) (4)
- Prenatal diagnosis of hereditary protein C deficiency. (1985) (4)
- Does first‐trimester serum pregnancy‐associated plasma protein A differ in pregnant women with sickle cell disease? (2019) (4)
- Screening for adverse pregnancy outcome by Ductus venosus Doppler at 11–13+6 weeks – Ductus venosus at 11–13+6 weeks (2008) (4)
- Rhesus disease: the model for fetal therapy. (1985) (4)
- Effect of delivery on fetal erythropoietin and blood gases in pregnancies with maternal diabetes mellitus. (1995) (4)
- Integrating doppler and biophysical parameters in management of intrauterine growth restriction (IUGR): Middle cerebral artery (MCA) doppler is irrelevant (2005) (4)
- First-Trimester Screening for Gestational Diabetes Mellitus in Twin Pregnancies (2021) (4)
- Metabolomic Prediction of Fetal Congenital Heart Defect in the First Trimester (2015) (4)
- Prenatal ultrasound diagnosis of Leroy I cell disease (2001) (4)
- Preterm and term pre‐eclampsia: Relative burdens of maternal and perinatal complications (2022) (4)
- Adrenal gland length in euploid and trisomy 18 fetuses at 11–13 weeks (2011) (4)
- FETAL GOITRE IN MATERNAL GRAVES' DISEASE. (2018) (4)
- Two- and three-dimensional imaging of coarctation shelf in the human fetus (2009) (4)
- [Systematic antepartum fetal evaluation ("Safe"). A concept for diagnosis of fetal function in threatened hypoxia]. (1993) (4)
- Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18. (1996) (4)
- Audit of Prenatal Diagnosis for Hemoglobin Disorders in the United Kingdom: The First Twenty Years (1998) (4)
- ISUOG Educational Series: The 11-14 weeks scan. (2003) (4)
- Maternal serum IGF-I, IGFBP-1 and IGFBP-3 at 11-13 weeks in trisomy 21 and trisomy 18 pregnancies. (2011) (4)
- Fetal platelet size and glycoprotein Ib and IIIa expression in diabetic pregnancies (1994) (4)
- Foetal brain development in offspring of women with psychosis. (2007) (4)
- Three‐dimensional echocardiography and cardiac strain imaging in women with gestational diabetes mellitus (2021) (4)
- Maternal hemodynamics at 11–13 weeks of gestation and the risk of pre-eclampsia (2011) (4)
- Maternal Serum Leptin at 11-13 Weeks Gestation in Normal andPathological Pregnancies (2012) (4)
- OC16b: Facial angle in fetuses with trisomy 21 at 11 to 13 + 6 weeks (2006) (4)
- Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30–33 weeks in the prediction of preeclampsia (2013) (3)
- Incidence of pre‐eclampsia: effect of deprivation (2022) (3)
- Sphenofrontal distance on three‐dimensional ultrasound in euploid and trisomy‐21 fetuses at 16–24 weeks' gestation (2016) (3)
- Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis. Case report. (1992) (3)
- First-Trimester Biochemical Markers of Aneuploidy and the Prediction of Small-for-Gestational Age Fetuses (2009) (3)
- ANTENATAL DIAGNOSIS OF CHRONIC GRANULOMATOUS DISEASE (1986) (3)
- Influence of birth weight on fetal cardiac indices at 35–37 weeks' gestation (2020) (3)
- First-trimester screening for trisomy 21 using nuchal translucency and nasal bone evaluations in a selected and an unselected population. (2007) (3)
- Diagnosis and management of fetal malformations. (1987) (3)
- Placental mRNA expression of alpha and beta human chorionic gonadotrophin in early trisomy 18 pregnancies. (1996) (3)
- 182 Improving Results with Percutaneous Fetal Endoscopic Tracheal Occlusion (FETO) for Severe Left Congenital Diaphragmatic Hernia. (2005) (3)
- Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies. (2003) (3)
- Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses (1999) (3)
- O-214 Removal of cervical mucus prior to embryo transfer does not improve pregnancy rates in IVF/ICSI O-216 Genome profiling of blocked embryos using whole genome amplification and genomic microarray and potential application for PGDAS (2006) (3)
- OS084. Maternal haemodynamics at 11-13 weeks of gestation and adverse pregnancy outcomes. (2012) (3)
- Intrathoracic extra‐mediastinal cystic hygroma in infancy (1994) (3)
- Quantitative cervical elastography in pregnancy: Reply (2012) (3)
- Midgestation cardiovascular phenotype in women who develop gestational diabetes and hypertensive disorders of pregnancy: comparative study (2022) (3)
- Fetal laryngeal obstruction (1992) (3)
- Contingent screening in stratification of pregnancy care based on risk of pre‐eclampsia at 19–24 weeks' gestation (2021) (3)
- First-Trimester Contingent Screening for Trisomies 21, 18, and 13 by Biomarkers and Maternal Blood Cell-Free DNA Testing (2014) (3)
- Mass spectral analysis of asymmetric hemoglobin hybrids: demonstration of Hb FS (alpha2gammabetaS) in sickle cell disease. (2001) (3)
- Vaginal progesterone in twin gestation with a short cervix: revisiting an individual patient data systematic review and meta‐analysis (2021) (3)
- ASPIRIN ADMINISTRATION FOR PREVENTION OF ADVERSE PREGNANCY OUTCOMES (2012) (3)
- OC270: Observed to expected lung area to head circumference ratio in the prediction of survival in fetuses with isolated diaphragmatic hernia (2007) (3)
- Amniotic fluid temperature change during first trimester amnifiltration (1994) (3)
- Monochorionic diamniotic twin pregnancy with selective fetal growth restriction Type II: sonographic and fetoscopic findings of poor prognosis (2017) (3)
- Antenatal testing to predict outcome in pregnancies with unexplained antepartum hemorrhage (1992) (3)
- OC06.01: Vaginal progesterone and the risk of preterm delivery in high‐risk twin gestations ‐ secondary analysis of a placebo‐controlled randomized trial (2011) (3)
- Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms‐like tyrosine kinase‐1 in women undergoing induction of labor (2019) (3)
- Detection of Embryonic Trisomy 21 in the First Trimester Using Maternal Plasma Cell-Free RNA (2022) (3)
- OC20.03: Hypertensive disorders in pregnancy: screening by uterine artery Doppler and blood pressure at 11–13 weeks (2009) (3)
- Blood pressure levels correlate with intra-individual variability using an automated device in early pregnancy (2008) (3)
- PREDICTION OF TERM SMALL FOR GESTATIONAL AGE BABIES USING FIRST TRIMESTER PLACENTAL VOLUME; A COMPARISON OF A NOVEL, FULLY AUTOMATED TECHNIQUE, OXNNET WITH A COMMERCIALLY AVAILABLE, SEMI-AUTOMATIC TOOL, VOCAL (TM) (2018) (3)
- The importance of gestational age in first trimester, maternal urine MALDI-Tof MS screening tests for Down Syndrome (2019) (3)
- Effect of Anaemia on Fetal Acid-Base Status (1988) (3)
- Is early delivery bene fi cial in gastroschisis ? (2014) (3)
- Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre‐eclampsia (2022) (3)
- First trimester combined screening in patients with systemic lupus erythematosus: impact of pre-analytical variables on risk assessment (2019) (3)
- Maternal haemodynamics at 11-13 weeks of gestation and adverse pregnancy outcomes (2012) (3)
- Neutrophil and monocyte β2‐integrin expression in trisomic fetuses (1995) (3)
- Elevation of prostaglandin levels in pregnancies complicated by premature rupture of the membranes (1992) (3)
- Fetal cardiac function at 35–37 weeks' gestation in pregnancies that subsequently develop pre‐eclampsia (2020) (3)
- Antenatal management of congenital diaphragmatic hernia: What's next ? (2022) (3)
- Articulated needle guide: report on the first 30 cases. (1989) (3)
- Central nervous system (1999) (3)
- Pro- and Anti-Angiogenic Markers as Clinical Tools for Suspected Preeclampsia with and without FGR near Delivery—A Secondary Analysis (2021) (3)
- Screening for nuchal translucency. Having the test gives parents options. (1998) (3)
- [Sonographic features of chromosomal defects in the second trimester of pregnancy]. (2005) (3)
- Ophthalmic artery peak systolic velocity ratio distinguishes pre‐eclampsia from chronic and gestational hypertension: A prospective cohort study (2021) (3)
- Screening for trisomies at 11-13 weeks' gestation: use of PAPP-A, PlGF or both. (2020) (3)
- TSH and FT4 Reference Intervals in Pregnancy: A Systematic Review and Individual Participant Data Meta-Analysis (2022) (3)
- Maternal Serum Inhibin-A Augments the Value of Maternal Serum PlGF and of sFlt-1/PlGF Ratio in the Prediction of Preeclampsia and/or FGR Near Delivery—A Secondary Analysis (2021) (3)
- Pregnancy loss rates after midtrimester amniocentesis. Authors' reply (2007) (3)
- Fetal serum ferritin and cobalamin in red blood cell isoimmunisation. (1995) (3)
- Potential biomarkers for predicting preterm birth in women with polycystic ovary syndrome (2013) (3)
- Nuchal translucency as a marker for Down syndrome in the first trimester (1997) (3)
- Immune and Non-immune Hy drops (1986) (3)
- Yolk Sac Diameter in Early Pregnancy in Maternal Diabetes Mellitus (2011) (3)
- Reference Ranges for the Pulsed wave Doppler of the Fetal Cardiac Inflow and Outflow Tracts from 13 to 36 Weeks Gestation: Short title: Zidere, Fetal inflow and outflow tract, Pulsed wave Doppler, z scores. (2021) (3)
- Fetal immunodeficiency: A consequence of placental insufficiency (1994) (3)
- P14 Significance and associations of aberrant right subclavian artery in the fetal cardiology setting (2016) (3)
- Fetal Major Cardiac Defects and Placental Dysfunction at 11–13 Weeks’ Gestation (2018) (2)
- Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia. (2020) (2)
- OP09.07: TTTS1 protocol: a cluster randomized controlled trial comparing a conservative management and primary laser surgery in stage 1 TTTS (2009) (2)
- [Increased nuchal translucency with normal karyotype]. (2005) (2)
- Changes in ophthalmic artery Doppler during acute blood‐pressure control in hypertensive pregnant women (2021) (2)
- Fetal heart rate at 10 to 14 weeks and birthweight (1997) (2)
- PlGF isoform 3 in maternal serum and placental tissue. (2019) (2)
- Doppler studies in pregnancies with maternal diabetes mellitus (2000) (2)
- 242: Impact of first trimester aspirin therapy on the population prevalence of pre-eclampsia (2008) (2)
- Doppler studies in fetal hypoxemic hypoxia Based on Doppler in Obstetrics (2017) (2)
- P45 Is it important to identify an isolated right aortic arch in fetal life? (2016) (2)
- Placental angiography of double survivors and double fetal deaths after laser for twin twin transfusion syndrome (TTTS) (2004) (2)
- Second and third trimester serum levels of HtrA1 in pregnancies affected by pre-eclampsia. (2021) (2)
- Erratum: Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks (2011) (2)
- Early prenatal diagnosis and fetal surgery (1987) (2)
- Sulfated Progesterone Metabolites That Enhance Insulin Secretion via TRPM3 Are Reduced in Serum From Women With Gestational Diabetes Mellitus (2022) (2)
- Thyroid function in anemic fetuses. (1990) (2)
- Improving results with percutaneous fetal endoscopic tracheal occlusion (FETO) for severe left congenital diaphragmatic hernia (2004) (2)
- Spheno‐frontal distance in euploid and trisomy 21 fetuses at 16–24 weeks’ gestation by three‐dimensional ultrasound (2016) (2)
- OC15.01: Analysis of cell‐free DNA in maternal blood in screening for aneuploidies updated meta‐analysis (2017) (2)
- Competing risks model for prediction of preeclampsia. (2021) (2)
- Endoscopic laser coagulation in the management of twin-twin transfusion syndrome (1996) (2)
- First trimester prenatal diagnosis (1992) (2)
- Giant cutaneous haemangioma with heart failure in a neonate: successful surgical treatment (2004) (2)
- Maternal plasma diacylglycerols and triacylglycerols in the prediction of gestational diabetes mellitus (2022) (2)
- The Role of Aspirin Dose on the Prevention of Preeclampsia and Fetal Growth Restriction: A Systematic Review and Meta-Analysis (2017) (2)
- Major cardiac defects and placental dysfunction at 11-13 weeks’ gestation: Cardiac defects and placental dysfunction (2017) (2)
- Fetal breathing movements and prostaglandin levels in pregnancies complicated by premature rupture of the membranes (1992) (2)
- First trimester angiogenic and inflammatory factors in women with chronic hypertension and impact of blood pressure control: a case–control study (2021) (2)
- Routine First-Trimester Screening for Fetal Trisomies in Twin Pregnancy: Cell-free DNA Test Contingent on Results From Combined Test (2019) (2)
- Prenatal Diagnosis of Aneuploidy Using Artificial Neural Networks in Relation to Health Economics (2016) (2)
- OC01.04: Aspirin versus placebo in pregnancies at high‐risk of preterm pre‐eclampsia a multicentre, double‐blind, placebo‐controlled trial (2017) (2)
- Prediction, diagnosis and management of twin-to-twin transfusion syndrome (1997) (2)
- A Multimodality Navigation System for Endoscopic Fetal Surgery: A Phantom Case Study for Congenital Diaphragmatic Hernia (2018) (2)
- Uterine artery Doppler at 11 + 0t o 13+ 6w eeks and 21 + 0t o 24+ 6w eeks in the prediction of pre-eclampsia (2008) (2)
- The implications of the Fetal Medicine Foundation 35-36 week preeclampsia prediction competing risk model on timing of birth. (2022) (2)
- Factors Associated with Placental Vascularization Measured by 3D Power Doppler Ultrasonographic Sphere Biopsy between 11 and 14 Weeks of Gestation (2018) (2)
- Ventilation-to-perfusion relationships and right-to-left shunt during neonatal intensive care in infants with congenital diaphragmatic hernia (2022) (2)
- First Trimester Prediction of Adverse Pregnancy Outcomes—Identifying Pregnancies at Risk from as Early as 11–13 Weeks (2022) (2)
- Screening for late preeclampsia at 35–37 weeks by the urinary Congo-red dot paper test (2021) (2)
- Using ultrasound and angiogenic markers from a 19-23 week assessment to inform the subsequent diagnosis of preeclampsia. (2022) (2)
- Sonographic measurement of cervical length ad fetal fibronectin testing in threatened preterm labor (2006) (2)
- First‐trimester screening for pre‐eclampsia: time to act (2017) (2)
- Cribado de parto pretérmino en el primer trimestre de la gestación (2014) (2)
- Aspirin did not prevent pre-eclampsia in women with abnormal uterine artery Doppler results (2004) (2)
- Nasal Bone in Screening for Trisomy 21 (2006) (2)
- Maternal Race and Stillbirth: Cohort Study and Systematic Review with Meta-Analysis (2022) (2)
- [Multiple pregnancy at 11+0 - 13+6 weeks]. (2006) (2)
- OC12.01: Suspicion of spina bifida at the 11–14 weeks scan (2010) (2)
- Is my baby alright? : a guide for expectant parents (1994) (2)
- OP06.09: Fetal lung‐to‐head ratio in the prediction of survival in severe left‐sided diaphragmatic hernia treated by fetal endoscopic tracheal occlusion (FETO) (2006) (2)
- Thyroid function in fetuses with chromosomal abnormalities: Authors' reply (1991) (2)
- Effect of maternal age on cardiac adaptation in pregnancy (2021) (2)
- Session 40: Embryo metabolism (2013) (2)
- Fetal blood gas and acid-base measurements must be corrected for gestational age. (1987) (1)
- Maternal human placental lactogen estimations in severe rhesus iso-immunisation before and after fetal intravascular transfusion (1988) (1)
- Cervical Pessary and Preterm Singleton Birth. (2016) (1)
- observational study abnormalities by rapid aneuploidy screening: prenatal diagnosis of chromosomal Fetal nuchal translucency scan and early (2008) (1)
- 402: Predictors of early neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia undergoing fetal endoluminal tracheal occlusion (FETO) (2011) (1)
- OP09.09: Total randomized controlled trial for moderate pulmonary hypoplasia due to congenital diaphragmatic hernia (CDH) (2009) (1)
- Abnormalities of the amniotic fluid volume (1999) (1)
- 622: Integrated fetal testing predicts all unexpected stillbirths in fetal growth restriction (FGR) (2007) (1)
- Anterior abdominal wall (1999) (1)
- Preeclampsia Prevention by Timed Birth at Term (2023) (1)
- Competing‐risks model for prediction of small‐for‐gestational‐age neonate at 36 weeks' gestation (2022) (1)
- Practical approach to obtain the mid‐sagittal plane of the fetal face at 11–13 weeks' gestation by two‐dimensional ultrasound (2014) (1)
- y-glutamyl transferase activity infetal serum, I maternal serum,andamniotic fluid during gestation (1984) (1)
- Effect of race on longitudinal central hemodynamics in pregnancy (2020) (1)
- OC32: Assessment of lung area in fetuses with congenital diaphragmatic hernia — a comparison of techniques (2006) (1)
- Ophthalmic artery Doppler at 35–37 weeks' gestation in pregnancies with small or growth‐restricted fetuses (2022) (1)
- Ultrasound in Obstetrics. (1998) (1)
- Isolation and freezing of human peripheral blood mononuclear cells from pregnant patients (2022) (1)
- Fetal renal artery blood velocimetry in multicystic kidney disease (1991) (1)
- 183 Lung-To-Head Ratio and Liver Position to Predict Outcome in Early Diagnosed Isolated Left Sided Diaphragmatic Hernia Fetuses: A Multicenter Study. (2005) (1)
- Percutaneous single port fetal endotracheal occlusion (FETO) for prenatal therapy of severe diaphragmatic hernia (2003) (1)
- Doppler studies in twin pregnancy : CHORIONICITY IN TWINS (2015) (1)
- Neutrophil and monocyte beta 2-integrin expression in trisomic fetuses. (1995) (1)
- The outcome of antenatally diagnosed talipes equinovarus (2001) (1)
- OC269: Prenatal prediction of neonatal morbidity in congenital diaphragmatic hernia: a multicenter study (2007) (1)
- 688: In fetal growth restriction (FGR), persistence of specific doppler abnormalities has differential consequences (2008) (1)
- Competing Risks Model for Prediction of Small for Gestational Age Neonates and the Role of Second Trimester Soluble Fms-like Tyrosine Kinase-1 (2021) (1)
- Maternal platelet size as a marker for fetal trisomies 18 and 13 (1995) (1)
- Neural tube abnormalities. (1989) (1)
- Effect of a Fetal Surveillance Unit on Admission of Antenatal Patients to Hospital (1992) (1)
- In utero therapy for congenital diaphragmatic hernia (2003) (1)
- OC38.03: One stop clinic for assessment of risk (OSCAR) for trisomy 21 in singleton pregnancies at 11 to 13 + 6 weeks of gestation (2005) (1)
- OC272: Prenatal prediction of survival using lung volume at magnetic resonance imaging and liver position in isolated diaphragmatic hernia: a multicenter study (2007) (1)
- VP48.08: The effect of race on longitudinal maternal central hemodynamics (2020) (1)
- The 11-14 weeks scan - Fetal nuchal translucency (2003) (1)
- Medical and psychological interventions after miscarriage and women's distress: a controlled study (2002) (1)
- 597: Metabolomic prediction of trisomy 18 first trimester pregnancies (2012) (1)
- Perinatal lung function measurement and prediction of respiratory morbidity in infants (1997) (1)
- Machine‐learning‐based prediction of pre‐eclampsia using first‐trimester maternal characteristics and biomarkers (2022) (1)
- In response to ‘certificate of competence in performing specific procedures or tests in screening practice’ (2004) (1)
- Cell Free Fetal and Total DNA Levels in Pregnancies at Risk of Sickle Cell Disease and Significant Ethnic Variation. (2006) (1)
- Fetomaternal BMI – A novel ultrasound predictor of obstetric anal sphincter injury (2010) (1)
- Gestation at delivery and outcome in CDH infants following fetoscopic tracheal occlusion (2012) (1)
- OC094: Outcome of trichorionic triplet pregnancies at 10–14 weeks after embryo reduction compared to expectant management (2003) (1)
- Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis (2022) (1)
- Authors' reply—Choroid plexus cysts and chromosomal defects (1991) (1)
- Treatment of congenital diaphragmatic hernia (2010) (1)
- Impact of Neuromuscular Blockade on Lung Function during the Initial Resuscitation of Infants with Congenital Diaphragmatic Hernia (2011) (1)
- Clinical value of a pathological examination in a case of first trimester trisomy 18. (1989) (1)
- METHODS OF MEASUREMENT OF Rh HAEMOLYTIC DISEASE (1995) (1)
- Development and initial experience with a manually controlled spring wire device ("Cordostat") to aid in difficult funipuncture. (1991) (1)
- [Are desquamated trophoblastic cells retrieved from the cervix suitable for a prenatal diagnosis?]. (1994) (1)
- OC11.05: Midbrain and falx in fetuses with absent corpus callosum at 11–13 weeks (2012) (1)
- Chronic fetal hypoxia in diabetic pregnancy: Authors' reply (1988) (1)
- Fetal therapy: progress made and lessons learnt (2011) (1)
- Routine assessment of cerebroplacental ratio at 35-37 weeks' gestation in the prediction of adverse perinatal outcome. (2019) (1)
- OC154: Pregnancy outcome of antenatally diagnosed agenesis of the corpus callosum (2004) (1)
- Imaging of the Fetus and the Uteroplacental Blood Supply: Ultrasound (2012) (1)
- Biophysical Markers of Suspected Preeclampsia, Fetal Growth Restriction and The Two Combined—How Accurate They Are? (2022) (1)
- Other mechanical effects (2015) (1)
- Blood Glucose and Oxygen Tension Levels in Small-for-Gestational-Age Fetuses (1989) (1)
- Fetal nasal bone in screening for Down’s syndrome (2006) (1)
- Nuchal translucency screening for chromosomal abnormalities in the first trimester (1996) (1)
- Fetal fraction of cell free DNA in screening for hypertensive disorders at 11–13 weeks (2021) (1)
- OC186: Cervical length at mid‐gestation and the risk of primary Cesarean section at term (2007) (1)
- Are all infants of diabetic mothers “macrosomic”?: Authors' reply (1989) (1)
- Are fetal cells retrieved from the cervix suitable for prenatal diagnosis (1994) (1)
- Ophthalmic artery Doppler at 11–13 weeks' gestation in prediction of pre‐eclampsia (2022) (1)
- When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. (2022) (1)
- Intrauterine laser photocoagulation for congenital lung malformations: late histopathological effects of a novel therapeutic intervention (2009) (1)
- OC48: Comparison of 3D ultrasound and MRI in assessing lung volumes in fetuses with diaphragmatic hernia (2006) (1)
- OC207: In utero therapy for congenital diaphragmatic hernia (2003) (1)
- OP14.12: Independent and combined contribution of cardiovascular Doppler parameters to short‐term prediction of mortality in severe IUGR (2008) (1)
- OP01.03: Comparison of 80 versus 160 mg of aspirin in pregnant women with previous history of pre-eclampsia: a randomised controlled trial (2015) (1)
- 312: Cerclage for short cervix on ultrasound in singleton gestations without prior preterm birth: meta-analysis of trials (2017) (1)
- Audit for prenatal diagnosis for haemoglobin disorders in the United Kingdom (1998) (1)
- Reference Ranges for Pulsed-Wave Doppler of the Fetal Cardiac Inflow and Outflow Tracts from 13 to 36 Weeks’ Gestation (2021) (1)
- The use of fetoscopy for prenatal diagnosis and treatment. (1983) (1)
- Gestación gemelar monocorial complicada con RCIU selectiva tipo 2: halazgos ecográficos y fetoscópicos de mal pronóstico (2016) (0)
- Doppler studies in maternal diabetes mellitus Based on Doppler in Obstetrics : by (2017) (0)
- OC31: Relation between lung‐to‐head ratio and lung volume in normal fetuses and fetuses with diaphragmatic hernia (2006) (0)
- Systemic innate immune response in the first trimester is related to DEFB1 genotype, and is distinct in women who develop PPROM and deliver before 34 weeks of gestation (2014) (0)
- Risk of major trisomies in relation to maternal age and gestation (1999) (0)
- Chorionic Villus Sampling at 11 to 13 Weeks of Gestation and Hypertensive Disorders in Pregnancy EDITORIAL COMMENT (2010) (0)
- In response to Wald (2004) (0)
- Iconographies supplémentaires de l'article : First-trimester metabolomic detection of late-onset preeclampsia (2012) (0)
- Invasive first trimester antenatal procedures and perinatal lung function (1996) (0)
- OC03.03: *The significance of first trimester subchorionic haematomas or ‘chorionic bumps’ (2012) (0)
- Percutaneous fetal endoscopic tracheal occlusion for isolated congenital diaphragmatic hernia with unfavourable prognosis (2010) (0)
- Contents Vol. 22, 2007 (2007) (0)
- Percutaneous fetoscopic endoluminal tracheal occlusion (FETO) for severe Congenital Diaphragmatic Hernia (2003) (0)
- Contents, Vol. 10, 1995 (1995) (0)
- Embryo reduction: a new model to study early pregnancy endocrinology (1997) (0)
- Psychological Impact and Women’s Evaluation of the First-Trimester Pre-Eclampsia Screening and Prevention: ASPRE Trial (2023) (0)
- Prenatal diagnosis of X-linked hydro-cephalus (1994) (0)
- Chapter 2 – Fetal Aneuploidies* (2015) (0)
- Audit of fetal biometry: understanding sources of error to improve our practice (2023) (0)
- The Baby Bio Bank of London (2009) (0)
- P51.03: The management and treatment of fetal hemolytic disease due to anti‐Ku alloimmunization with serial intrauterine transfusions to the fetus and recombinant erythropoietin to the mother (2007) (0)
- Reply: To PMID 23939754. (2014) (0)
- Evaluation of lower uterine segment morphology at 23 weeks gestation. A prospective observational study (2004) (0)
- Contents, Vol. 10, 1995 (1995) (0)
- Congenital diaphragmatic hernia (CDH) – Influence of fetoscopic tracheal occlusion on outcomes (2015) (0)
- Contents Vol. 33, 2013 (2013) (0)
- Severe twin to twin transfusion syndome: diagnosis and endoscopic laser coagulation (1998) (0)
- PP.16 Pregnancy Outcomes in Women with Known Sickle Cell Disease: A Case Control Study from a Dedicated Tertiary Joint Obstetric Sickle Cell Clinic (2013) (0)
- Reply (2022) (0)
- Color flow imaging (2015) (0)
- Preterm preeclampsia is an important cause of maternal and perinatal death and complications. It is uncertain whether the intake of low-dose aspirin during preg- nancy reduces the risk of preterm preeclampsia (2019) (0)
- Management of fetal pleural effusions (1998) (0)
- Subject Index Vol. 28, 2010 (2010) (0)
- Nuchal translucency and gestational age. Authors' reply (2004) (0)
- OC066: Mid trimester screening for pre‐eclampsia using transvaginal uterine artery Doppler and maternal demographic characteristics in 16 806 pregnancies (2004) (0)
- Reply (2004) (0)
- LA ADMINISTRACIÓN DE PROGESTERONA POR VÍA VAGINAL A MUJERES CON ACORTAMIENTO DEL CUELLO UTERINO ASINTOMÁTICO DETECTADO POR ECOGRAFÍA EN EL SEGUNDO TRIMESTRE DISMINUYE EL PARTO PRETÉRMINO Y LA MORBILIDAD NEONATAL: REVISIÓN SISTEMÁTICA Y METAANÁLISIS DE DATOS DE PACIENTES INDIVIDUALES (2012) (0)
- P06.11: Later TO for severe congenital diaphragmatic hernia yields less pulmonary response for lungs of comparable size (2006) (0)
- j. Permat. Med. Invasive techniques for prenatal diagnosis and therapy (1987) (0)
- Impact of New Definitions of Preeclampsia at Term on Identification of Adverse Maternal and Perinatal Outcomes (2022) (0)
- Comments on the Article about the Correlation between Maternal Serum Concentrations of Progesterone-Induced Blocking Factor Taken at 11-13 Weeks' Gestation and Spontaneous Preterm Delivery before 34 Weeks Reply (2011) (0)
- Contents Vol. 30, 2011 (2011) (0)
- 579: Overcoming the barrier of non specificity of fetal cell antigens: I mproved yield of circulating fetal cells utilizing automated microscopy for detection of aneuploidy (2007) (0)
- OC3.04: Short‐term outcome of trichorionic triplet pregnancies at 10–14 weeks: embryo reduction compared to expectant management (2005) (0)
- plasma throughout pregnancy . function in fetal and maternal to renal , hepatic , and bone biochemical substances relating Normal reference ranges for (0)
- OC08.01: Effective screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation (2016) (0)
- P11.12: Effect of deviation of free β‐hCG and PAPP‐A on the performance of screening for trisomy 21 (2009) (0)
- OC17.03: *Maternal hemodynamics in screen‐positive and screen‐negative women of the ASPRE trial (2020) (0)
- Prenatal nutritional stress and postnatal growth in an experimental model (2011) (0)
- New Advances in Cell-Free DNA Analysis of Maternal Blood (2014) (0)
- Women’s Health and Wellness (2020) (0)
- Reply (2014) (0)
- Fetal cardiac function at midgestation and conception by in‐vitro fertilization (2023) (0)
- Contents Vol. 29, 2011 (2011) (0)
- P04.03: Frontomaxillary facial angle at 11 + 0 to 13 + 6 weeks in Chinese population (2010) (0)
- 271: First trimester maternal levels of adiponectin, lipids and lipoproteins in women who subsequently develop gestational diabetes mellitus (2009) (0)
- Doppler studies in preterm prelabor amniorrhexis (2000) (0)
- OC17.06: Maternal cardiac function in women at high‐risk for pre‐eclampsia treated with 150mg aspirin or placebo: an observational study (2020) (0)
- Contents, Vol. 9, 1994 (1994) (0)
- Areallinfants ofdiabetic mothers "macrosomic"? (1989) (0)
- P03.06: First‐trimester sonographic features of trisomy 13 (2005) (0)
- PERSONALIZED STRATIFICATION OF PREGNANCY CARE FOR SMALL FOR GESTATIONAL AGE NEONATES FROM BIOPHYSICAL MARKERS AT MID-GESTATION. (2022) (0)
- Fetal karyotyping: which technique at what gestation? (1991) (0)
- OC040: Absent nasal bone at 11–14 weeks of gestation and chromosomal defects (2003) (0)
- OC15.04: Predictors of early neonatal morbidity in fetuses with severe isolated congenital diaphragmatic hernia (CDH) undergoing fetal endoluminal tracheal occlusion (FETO) (2011) (0)
- 4.2 Variation in Beta Defensin 1 Genotype is Associated with Preterm Birth (2013) (0)
- Contents, Vol. 3, 1988 (1988) (0)
- The sensitivity of Doppler studies vs. biochemical indices in predicting fetal outcome in cases of pregnancy induced hypertension (2001) (0)
- International Society ‘The Fetus as a Patient’ VII. International Congress 1991 (1991) (0)
- Reply (2019) (0)
- Fetal therapy (1994) (0)
- 5.4 First trimester Angiotensinogen: Kallikrein ratio is raised in women who develop severe early-onset pre-eclampsia (2014) (0)
- Aspirin for prevention of preterm preeclampsia (2018) (0)
- Ultrasound screening at 10-14 weeks-Fetal Medicine Foundation Manual. (1996) (0)
- Incidence of stillbirth: effect of deprivation (2022) (0)
- Metabolomic Analysis for First Trimester Down Syndrome Prediction (2015) (0)
- FIRST TRIMESTER ANGIOTENSINOGEN: KALLIKREIN RATIO IS RAISED IN WOMEN WHO DEVELOP SEVERE EARLY-ONSET PRE-ECLAMPSIA (2014) (0)
- HUMAN FETAL AND MATERNAL PLASMA AMINO ACID LEVELS IN NORMAL AND INTRAUTERINE GROWTH RETARDED (IUGR) GESTATIONS (1987) (0)
- VP47.05: Maternal plasma diacylglycerol and triacylglycerol in the prediction of gestational diabetes mellitus (2020) (0)
- Lung assessment for prediction of outcome in isolated congenital diaphragmatic hernia (2008) (0)
- Placental insufficiency and redistribution in the fetal circulation (2015) (0)
- Reply (2021) (0)
- Antenatal Imaging and Therapy (2003) (0)
- Optimisation of a convolutional neural network to segment the first trimester placenta from 3D ultrasound scans (2018) (0)
- Authors' reply. (2023) (0)
- Ductus venosus and chromosomal abnormalities 513 Table 1 Studies reporting on the incidence of abnormal flow in the ductus venosus in the first trimester in euploid fetuses (2009) (0)
- Syngelaki Argyro (Orcid ID: 0000-0001-5856-6072) Competing-risks model for prediction of small-for-gestational-age neonates from estimated fetal weight at 19–24 weeks’ gestation (2021) (0)
- Re: Prediction of pre‐eclampsia: review of reviews (2019) (0)
- 843: Prenatal brain growth is altered in Congenital Diaphragmatic Hernia on ultrasound (2020) (0)
- Biophysical profile score (BPS) as a predictor of poor outcome in preterm fetal growth restriction (FGR): A multicenter study (2006) (0)
- AUTHORS' REPLY (1995) (0)
- Reply (2012) (0)
- Prediction of future chronic hypertension from maternal characteristics in early pregnancy (2023) (0)
- P325: Prenatal diagnosis and management of extralobar lung sequestration: two case reports (2003) (0)
- Subject Index Vol. 22, 2007 (2007) (0)
- Fetal breathing movements (2015) (0)
- O-23 Metabolic profiling of the human embryo on day 5 and its relationship to chromosomal abnormalities (2013) (0)
- OS027. Ethnicity and adverse pregnancy outcomes: A cohort study. (2012) (0)
- OC032: Fetoscopic endoluminal tracheal occlusion (FETO) for severe congenital diaphagmatic hernia (2004) (0)
- 745: Determinants of cardiovascular deterioration in fetal growth restriction (FGR) (2007) (0)
- Prediction of successful induction of labour by pre-induction sonographic measurement of cervical length and parity (2003) (0)
- Lung-to-head ratio to predict neonatal survival in isolated right sided diaphragmatic hernia fetuses: A multicenter study (2006) (0)
- OC01.04: Contingent model for the prediction of delivery of small‐for‐gestational age neonates (2016) (0)
- Suspected twin anemia polycythemia sequence in a dichorionic, diamniotic twin pregnancy: a case report (2023) (0)
- Lung volume assessment with 3D ultrasound and liver position to predict postnatal outcome in fetuses with isolated congenital diaphragmatic hernia (2006) (0)
- Concentration offetal plasma andamniotic fluid interleukin-1 inpregnancies complicated bypreterm prelabour amniorrhexis (1995) (0)
- Gestational hormone and protein measurements in women with an unexplained maternal serum a-fetoprotein elevation (1990) (0)
- Ophthalmic artery Doppler at 19–23 weeks' gestation in pregnancies that deliver small‐for‐gestational‐age neonates (2022) (0)
- Poster session IIDiabetes, doppler, labor, ultrasound-imaging274: Maternal arterial stiffness in pregnancies complicated by gestational and type 2 diabetes mellitus (2009) (0)
- The safety of fetoscopy: (II). Effect on maternal plasma levels of 13,14-dihydro-15-oxo-prostaglandin F2 alpha. (1983) (0)
- Human erythrocyte SOD in adults and normal, hypoxaemic, and anaemic foetuses. (1991) (0)
- Preeclampsia. Reply. (2022) (0)
- Hypoxemic hypoxia (uteroplacental insufficiency) (2015) (0)
- PATHOLOGICAL FINDINGS IN PRE-ECLAMPSIA AND INTRAUTERINE GROWTH RESTRICTION (2015) (0)
- Renal arterybloodflowvelocity inverylow birthweight infants withintrauterine growth retardation (2011) (0)
- Maternal Plasma RNA in First Trimester Nullipara for the Prediction of Spontaneous Preterm Birth ≤ 32 Weeks: Validation Study (2023) (0)
- First Trimester Preterm Preeclampsia Prediction with Metabolite Biomarkers: Differential Prediction According to Maternal Body Mass Index. (2022) (0)
- In utero fetoscopic surgery for congenital diaphragmatic hernia (2005) (0)
- Computerized fetal heart rate analysis (CCTG) for prediction of acidemia in fetal growth restriction (IUGR) (2005) (0)
- Atypicality index: avoiding false reassurance in prenatal screening (2022) (0)
- Preeclampsia Prediction and Management Obstetrics and Gynecology International Preeclampsia Prediction and Management (2014) (0)
- Predictors of necrotizing entercolitis (NEC) in fetal growth restriction (IUGR) (2005) (0)
- Comparison of diagnostic accuracy of early screening for preeclampsia by NICE guidelines and a Bayes theorem based method: Early screening for pre-eclampsia (2018) (0)
- 234. Maternal cardiovascular function at 35–37 weeks’ gestation: Normal vs hypertensive disorders of pregnancy (2018) (0)
- Muestreo de defectos cormosómicos por translucidez de la nuca fetal, de 11 a 14 semanas (2002) (0)
- OC271: Comparison of fetal lung area to head circumference ratio with contralateral lung volume in the prediction of postnatal outcome in diaphragmatic hernia (2007) (0)
- 749: Identification of predictive biomarkers for pre-eclampsia by plasma proteomic profiling (2011) (0)
- Umbilical cord erythrobalst count as an index of antenatal and intrapartum fetal asphyxia (1994) (0)
- Vascular phenotype at 35–37 weeks' gestation in women with gestational diabetes mellitus (2022) (0)
- OC15.01: Neonatal morbidity in fetuses with severe isolated CDH in the FETO era (2011) (0)
- Fetoscopic intervention: Twin-twin transfusion syndrome (1995) (0)
- Identifying Robertsonian Translocation Carriers by Microarray-Based DNA Analysis (2016) (0)
- Reply (2016) (0)
- OC218: Update on fetal endoscopic tracheal occlusion for severe left‐sided isolated diaphragmatic hernia (2007) (0)
- P277: Sonographic cervical length in singleton pregnancies with intact membranes presenting with threatened preterm labour (2003) (0)
- Semiquantitative immunohistochemical localisation of PAPP-A and beta-hCG in first trimester chorionic villi from euploid and trisomic pregnancies (2000) (0)
- Correlation Between DEFB Copy Number and Serum hBD2 Expression Is Disrupted in Pregnancy and DEFB Copy Number Variation Is Not Associated With Preterm Birth (2015) (0)
- Impact of maternal height, weight at presentation and gestational weight gain on cardiac adaptation in pregnancy (2022) (0)
- Contents, Vol. 1, 1986 (1983) (0)
- The value of three-dimensional ultrasound in identifying Mullerian anomalies at risk of adverse pregnancy outcomes (2020) (0)
- OC87: Uterine artery Doppler and cervical assessment in the prediction of early preterm delivery (2006) (0)
- OC217: Results of fetal endoscopic tracheal occlusion beyond 29 weeks (2007) (0)
- O-174 The association of chromosomal abnormalities with embryo ultrastructure, spindle anomalies and metabolic profiling (2022) (0)
- Fetal circulation and cardiac output (1993) (0)
- Maternal Cardiac Function in Women at High Risk for Pre-eclampsia Treated With 150 mg Aspirin or Placebo: An Observational Study (2021) (0)
- OP10.03: Added value of website based parent information about intrauterine treatment for severe congenital diaphragmatic hernia (2013) (0)
- Indicators of platelet turnover in thrombocytopenic infants (1997) (0)
- OC084: Sonographic estimation of fetal weight in term pregnancies prior to induction of labour (2003) (0)
- Contents Vol. 31, 2012 (2012) (0)
- Kidneys and urinary tract (1999) (0)
- Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks' gestation). (1997) (0)
- OC88: Can uterine artery Doppler predict in utero fetal death? (2006) (0)
- Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies (2019) (0)
- LAADMINISTRACIÓNDEPROGESTERONAPOR VÍAVAGINALAMUJERESCONACORTAMIENTO DELCUELLOUTERINOASINTOMáTICO DETECTADOPORECOGRAFÍAENELSEGUNDO TRIMESTREDISMINUYEELPARTOPRETéRMINO YLAMORBILIDADNEONATAL: REVISIÓNSISTEMáTICAYMETAANáLISIS DEDATOSDEPACIENTESINDIVIDUALES (2012) (0)
- OC30: Updated results of the FETO task group as a prelude to setup of clinical trials (2006) (0)
- Ultrasound Guided Procedures in Small-For-Gestation (2020) (0)
- Evaluation of Human Chorionic Gonadotropin -Sub- unit mRNA Concentrations in Maternal Serum in An- euploid Pregnancies: A Feasibility Study, Enders K.O. (2004) (0)
- [The use of fetoscopy in fetal therapy]. (1984) (0)
- Incorporating the Probability of Competing Event(s) into the Preeclampsia Competing Risk Algorithm. (2019) (0)
- Abstracts of the 26th World Congress on Ultrasound in Obstetrics and Gynecology, Rome, Italy, 24-28 September 2016. (2016) (0)
- CHORIONIC VILLUS SAMPLING AND EARLY AMNIOCENTESIS FOR PRENATAL DIAGNOSIS. AUTHORS' REPLY (1997) (0)
- Multifetal pregnancy reduction (1997) (0)
- OC30.06: Improving results with percutaneous fetal endoscopic tracheal occlusion (FETO) for severe left congenital diaphragmatic hernia: a controlled study (2005) (0)
- Cerebellar hypoplasia, facial dysmorphism and internal abnormalities: a new recessive syndrome? (1998) (0)
- Subject Index Vol. 10, 1995 (1995) (0)
- Placental mRNA expression of a and p human chorionic gonadotrophin in early trisomy 18 pregnancies (2005) (0)
- Lung volumes in fetuses with diaphragmatic hernia: comparison of 3D US and MR imaging assessments (2007) (0)
- Antenatal sonographic findings in skeletal dysplasias (1999) (0)
- FETAL BREATHING MOVEMENTS, NOT AMNIOTIC FLUID VOLUME, PRESERVE ANTENATAL LUNG GROWTH (1987) (0)
- Pathogenesis of Preeclampsia – from Immunology to Angiogenesis Inhibition (2010) (0)
- Maternal cardiac function in twin pregnancy at 19–23 weeks' gestation (2022) (0)
- Contents Vol. 28, 2010 (2010) (0)
- UMBILICAL ARTERY FLOW (2015) (0)
- OP02.20: Pattern of lung growth through the latter half of pregnancy in fetuses with isolated diaphragmatic hernia and prenatal prediction of survival (2006) (0)
- [Transparent nuclei as a marker of congenital heart disease: 1,682 fetuses with transparent nuclei > or = 2.5 mm]. (1999) (0)
- Subject Index Vol. 10, 1995 (1995) (0)
- OP01.09: Nasal bone evaluation in prenatal screening for trisomy 21: a review (2006) (0)
- The safety of fetoscopy: (II). Effect on maternal plasma levels of 13,14‐dihydro‐15‐oxo‐prostaglandinf2α (1983) (0)
- Integrated fetal testing is the most accurate predictor of perinatal outcome in intrauterine growth restriction (IUGR) (2005) (0)
- OC113: Abnormal ductus venosus Doppler independently predicts poor perinatal outcome in fetuses delivered for severe early placental insufficiency: a multicenter cohort study (2006) (0)
- Can intra-uterine mortality be reduced in Nd-YAG laser treatment of Twin-Twin Transfusion Syndrome? An analysis (1995) (0)
- 795: First trimester dysregulation of single carbon metabolism and prediction of preeclampsia (2012) (0)
- WS10: Chromosomopathies WS10‐01Pathophysiology of increased nuchal translucency‐abnormalities of the extracellular matrix (2000) (0)
- Contents Vol. 35, 2014 (2014) (0)
- OC24: First‐trimester intrauterine growth restriction in fetuses with chromosomal abnormalities (2006) (0)
- Reply: To PMID 23107079. (2013) (0)
- Doppler evaluation of fetal anemia (1986) (0)
- OC14.02: Lung‐to‐head ratio and liver position to predict outcome in early diagnosed isolated left sided diaphragmatic hernia fetuses: a multicenter study (2005) (0)
- 540: Cardiovascular deterioration in fetal growth restriction (FGR) progresses in three characteristic patterns (2007) (0)
- PROLONGED AND PREMATURE RUPTURE OF THE MEMBRANES (PPROM) AND ITS RELATIONSHIP TO CHRONIC RESPIRATORY MORBIDITY (1989) (0)
- VP50.20: Second and third trimester serum levels of HtrA1 in the prediction of pre‐eclampsia (2020) (0)
- BSTETRICS irst-trimester maternal plasma cell-free etal DNA and preeclampsia (0)
- P20.03: Clinical progression to stillbirth in fetal growth restriction (2009) (0)
- SEGMENTATION OF THE PLACENTA IN EARLY STAGE PREGNANCY 3D ULTRASOUND USING DEEP LEARNING (2016) (0)
- Rapid DNA quantification in the prenatal diagnosis of fetal triploidy (1993) (0)
- P40.18: The antenatal and postnatal management in a case of pulmonary sequestration (2007) (0)
- First Trimester Folate Metabolism and Congenital Heart Defect (2011) (0)
- Short cervix on midtrimester USS screening: what outcome for the low risk population? (2010) (0)
- Congenital heart disease Maternal and foetal angiogenic imbalance in congenital heart defects (2014) (0)
- Parathryroid hormone related peptide in normal human development (1990) (0)
- Galectin-7: A Novel Placental-released Driver of Preeclampsia. (2020) (0)
- Contents Vol. 24, 2013 (2013) (0)
- A Step Closer to Utilising Metabolite Biomarkers to Improve Early Pregnancy Prediction of Preeclampsia. (2023) (0)
- Inhibin-A Augments Plgf and the Sflt-1 / Plgf Ratio in the Prediction of Preeclampsia and / or Fgr near Delivery (2020) (0)
- Contingent Screening for Small by Weight for Gestational Age Neonates. (2016) (0)
- Fetal therapy. (1994) (0)
- Web Sites Providing Useful Information for Prenatal Diagnosis (1999) (0)
- Comparison of ophthalmic artery Doppler with PlGF and sFlt‐1/PlGF ratio at 35–37 weeks' gestation in prediction of imminent pre‐eclampsia (2022) (0)
- Contents Vol. 24, 2013 (2013) (0)
- Author's response to reviews Endothelial Nitric Oxide Synthase Gene Polymorphism (Glu298Asp) and Development of Title: Pre-eclampsia: a nested case-control study and a meta-analysis. Authors: (2005) (0)
- Dataset A Training Validation Grid search Optimal parameters Datasets B and C Training Validation ANN Results (2016) (0)
- Table of Contents (2020) (0)
- 112 ELEVATION OF PROSTAGLANDIN LEVELS IN PREGNANCIES COMPLICATED BY PREMATURE RUPTURE OF THE MEMBRANES (PROM) (1991) (0)
- Prediction of the severity of pre-eclampsia by utero-placental Doppler studies (1993) (0)
- Bone quality is associated with perinatal nutritional manipulation in adult Wistar rats offspring (2020) (0)
- OC140: Assessing the risk of spontaneous preterm birth using ultrasonic cervical length measurement and maternal characteristics (2007) (0)
- Congenital diaphragmatic hernia: clinical antenatal management (2012) (0)
- Endothelial progenitor cells and pregnancy REPLY (2009) (0)
- 14th World Congress on Ultrasound in Obstetrics and Gynecology—Scientific Program (2004) (0)
- 82: First-trimester metabolomic prediction of gestational diabetes (GDM) (2017) (0)
- Effect of perinatal nutritional patterns on skeletal properties in adult Wistar rat offspring (2021) (0)
- Estimated fetal weight at mid‐gestation in prediction of pre‐eclampsia in singleton pregnancy (2021) (0)
- P JThompson, AnneGreenough, K Nicolaides (1990) (0)
- Doppler studies in red blood cell isoimmunization : PATHOPHYSIOLOGY (2015) (0)
- The value of three-dimensional ultrasound in identifying Mullerian anomalies at risk of adverse preg (2020) (0)
- Reply (2020) (0)
- 132: First-trimester metabolomics prediction of subsequent stillbirth (2016) (0)
- Fetal plasma erythropoietin concentration in red blood cell‐isoimmunized pregnancies (1993) (0)
- The long-term outcome following thoraco-amniotic shunting for congenital lung malformations. (2022) (0)
- OC02.05: *Fetoscopic endoluminal tracheal occlusion reverses the natural history of right‐sided congenital diaphragmatic hernia: a European multicentre experience (2020) (0)
- Contents Vol. 32, 2012 (2012) (0)
- Honored Lecture and Award Recipients (2004) (0)
- OC07.05: Longitudinal maternal cardiac function and fetal biometry in a general obstetric population (2020) (0)
- Interpretation of FHR Patterns of SGA Fetuses in Correlation to Fetal Blood Gas Values Obtained Via Cordocentesis (1992) (0)
- OP20.08: Holoprosencephaly, megacystis and exomphalos and the risk for chromosomal abnormalities (2009) (0)
- GWAS Identified Inflammatory Polymorphisms Do Not Improve Clinical Markers for Predicting Preterm Birth in an Antenatal Population (2015) (0)
- OC112: Integrated fetal testing most accurately predicts perinatal outcome in intrauterine growth restriction (IUGR) (2006) (0)
- OP14.10: Predictors of cardiovascular deterioration in placenta‐based fetal growth restriction (FGR) (2008) (0)
- Reply (2003) (0)
- Cervical Dilation with Lamicel Prior to Hysteroscopy (1983) (0)
- OC10.01: ASPRE trial: incidence of preterm pre‐eclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm (2018) (0)
- Paediatric Pathology Society Annual Meeting, Helsinki, Finland, September 2008 (2010) (0)
- Maternal cardiac output in normal and complicated pregnancy (1993) (0)
- Ultrasonographic appearance of the upper and lower uterine segments in pregnancy: Longitudinal observational study (2004) (0)
- transfusion syndrome . atresia in a case of twin to twin Temporary iatrogenic fetal tricuspid valve (0)
- OC29: Proposed trials for in utero therapy for severe isolated left‐sided congenital diaphragmatic hernia (2006) (0)
- OC042: Five years experience of screening for chromosomal anomalies in a 1st trimester OSCAR clinic (2003) (0)
- Subarachnoid space diameter in chromosomally abnormal fetuses at 11–13 weeks’ gestation (2019) (0)
- Using deep learning to develop a fully automated, real-time 3D-ultrasound segmentation tool to estimate placental volume in the first trimester. (2018) (0)
- 207: First trimester prediction of HELLP syndrome (2015) (0)
- Implementation of Maternal Blood Cell Free DNA Testing in Early Screening for Aneuploidies (2019) (0)
- OC33: Left and right lung volumes in fetuses with diaphragmatic hernia (2006) (0)
- Reply to High dose progesterone for prevention of preterm birth in twins. (2021) (0)
- Future IEC standards (2015) (0)
- Embryo-fetal erythroid cell selection from celomic fluid allows earlier antenatal diagnosis of hemoglobinopathies: Earlier antenatal diagnosis of hemoglobinopathies by celocentesis (2016) (0)
- Competing‐risks model for pre‐eclampsia and adverse pregnancy outcomes (2022) (0)
- 399: Added value to the prenatal counseling by standardized website based information about intrauterine treatment for severe congenital diaphragmatic hernia (2012) (0)
- T6.1 Chorionic villus sampling at 11-13 weeks' gestation and hypertensive disorders (2010) (0)
- The Role of Echography in the Diagnosis of Fetal Chromosomal Defects (1991) (0)
- Subject Index Vol. 9, 1994 (1994) (0)
- First trimester prenatal diagnosis of trisomy 21 in discordant twins using fetal nuchal translucency thickness and maternal serum free b-hCG and PAPPA Screening for trisomy (0)
- Reply (2017) (0)
- Contents, Vol. 5, 1990 (1990) (0)
- Cervical cerclage for short cervix at 24-26 weeks of gestation: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. (2023) (0)
- Contents, Vol. 6, 1991 (1991) (0)
- Clinical Implementation of Routine Screening for Fetal Trisomies in the UK NHS: Cell-Free DNA Test Contingent on Results From First-Trimester Combined Test (2016) (0)
- Can quantification of Serum Glycans predict Pre-Eclampsia? (2018) (0)
- Gene Expression of Human Pregnancy-associated Placenta from Trisomic Pregnancies Plasma Protein-A in (1996) (0)
- ASPRE trial: effects of aspirin on mean arterial blood pressure and uterine artery pulsatility index trajectories in pregnancy. (2023) (0)
- Contents, Vol. 5, 1990 (1990) (0)
- Doppler studies in maternal autoimmune disease (2000) (0)
- Longitudinal maternal cardiac function in hypertensive disorders of pregnancy. (2022) (0)
- Longitudinal assessment of infant lung function following pregnancies complicated by prolonged and preterm rupture of the membranes (1992) (0)
- Reply (2018) (0)
- Prevention of Stillbirth: Impact of Two-Stage Screening for Vasa Previa (2020) (0)
- FETAL NUCHAL TRANSLUCENCY : ULTASOUND SCREENING FOR FETAL TRISOMY IN THE FIRST TRIMESTER OF PREGANCY. AUTHORS' REPLY (1995) (0)
- Characteristics of randomized trials that evaluated the impact of low-dose aspirin initiated at ≤ 16 weeks ’ gestation on the risk of preeclampsia (2014) (0)
- 11A Antenatal imaging and therapy (2003) (0)
- OP02.02: Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21 (2009) (0)
- Rapidprocessing offetal skin forprenatal diagnosis bylight andelectron microscopy (1984) (0)
This paper list is powered by the following services:
Other Resources About Kypros Nicolaides
What Schools Are Affiliated With Kypros Nicolaides?
Kypros Nicolaides is affiliated with the following schools:
